<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:53:28Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4068365" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4068365</identifier><datestamp>2014-06-26</datestamp><setSpec>elsevierwt</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Mol Biol</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Mol. Biol</journal-id>
      <journal-title-group>
        <journal-title>Journal of Molecular Biology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0022-2836</issn>
      <issn pub-type="epub">1089-8638</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4068365</article-id>
      <article-id pub-id-type="pmcid">PMC4068365</article-id>
      <article-id pub-id-type="pmc-uid">4068365</article-id>
      <article-id pub-id-type="pmid">23017427</article-id>
      <article-id pub-id-type="publisher-id">S0022-2836(12)00770-X</article-id>
      <article-id pub-id-type="doi">10.1016/j.jmb.2012.09.013</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Solution Structure of CCP Modules 10â12 Illuminates Functional Architecture of the Complement Regulator, Factor H</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Makou</surname>
            <given-names>Elisavet</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mertens</surname>
            <given-names>Haydyn D.T.</given-names>
          </name>
          <xref rid="af0010" ref-type="aff">2</xref>
          <xref rid="fn0005" ref-type="fn">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maciejewski</surname>
            <given-names>Mateusz</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Soares</surname>
            <given-names>Dinesh C.</given-names>
          </name>
          <xref rid="af0015" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Matis</surname>
            <given-names>Ilias</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schmidt</surname>
            <given-names>Christoph Q.</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">1</xref>
          <xref rid="fn0005" ref-type="fn">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Herbert</surname>
            <given-names>Andrew P.</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Svergun</surname>
            <given-names>Dmitri I.</given-names>
          </name>
          <xref rid="af0010" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barlow</surname>
            <given-names>Paul N.</given-names>
          </name>
          <email>Paul.Barlow@ed.ac.uk</email>
          <xref rid="af0005" ref-type="aff">1</xref>
          <xref rid="cr0005" ref-type="corresp">â</xref>
        </contrib>
      </contrib-group>
      <aff id="af0005"><label>1</label>Schools of Chemistry and Biological Sciences, University of Edinburgh, West Mains Road, Edinburgh EH9 3JJ, UK</aff>
      <aff id="af0010"><label>2</label>European Molecular Biology Laboratory Hamburg Outstation, c/o Deutsches ElektronenâSynchrotron, Notkestrasse 85, 22603 Hamburg, Germany</aff>
      <aff id="af0015"><label>3</label>Medical Genetics Section, Molecular Medicine Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK</aff>
      <author-notes>
        <corresp id="cr0005"><label>â</label>Corresponding author. <email>Paul.Barlow@ed.ac.uk</email></corresp>
        <fn id="fn0005">
          <label>1</label>
          <p>Present addresses: H. D. T. Mertens, Australian Synchrotron, 800 Blackburn Road, Clayton VIC 3168, Australia; C. Q. Schmidt, Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, Helmholtzstrasse 20, D-89081 Ulm, Germany.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>14</day>
        <month>12</month>
        <year>2012</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
      <pub-date pub-type="ppub">
        <day>14</day>
        <month>12</month>
        <year>2012</year>
      </pub-date>
      <volume>424</volume>
      <issue>5</issue>
      <fpage>295</fpage>
      <lpage>312</lpage>
      <history>
        <date date-type="received">
          <day>7</day>
          <month>8</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>17</day>
          <month>9</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>9</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2012 Elsevier Ltd.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <copyright-holder>Elsevier Ltd</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>The 155-kDa plasma glycoprotein factor H (FH), which consists of 20 complement control protein (CCP) modules, protects self-tissue but not foreign organisms from damage by the complement cascade. Protection is achieved by selective engagement of FH, via CCPs 1â4, CCPs 6â8 and CCPs 19â20, with polyanion-rich host surfaces that bear covalently attached, activation-specific, fragments of complement component C3. The role of intervening CCPs 9â18 in this process is obscured by lack of structural knowledge. We have concatenated new high-resolution solution structures of overlapping recombinant CCP pairs, 10â11 and 11â12, to form a three-dimensional structure of CCPs 10â12 and validated it by small-angle X-ray scattering of the recombinant tripleâmodule fragment. Superimposing CCP 12 of this 10â12 structure with CCP 12 from the previously solved CCP 12â13 structure yielded an S-shaped structure for CCPs 10â13 in which modules are tilted by 80â110Â° with respect to immediate neighbors, but the bend between CCPs 10 and 11 is counter to the arc traced by CCPs 11â13. Including this four-CCP structure in interpretation of scattering data for the longer recombinant segments, CCPs 10â15 and 8â15, implied flexible attachment of CCPs 8 and 9 to CCP 10 but compact and intimate arrangements of CCP 14 with CCPs 12, 13 and 15. Taken together with difficulties in recombinant production of module pairs 13â14 and 14â15, the aberrant structure of CCP 13 and the variability of 13â14 linker sequences among orthologues, a structural dependency of CCP 14 on its neighbors is suggested; this has implications for the FH mechanism.</p>
      </abstract>
      <abstract abstract-type="graphical">
        <sec>
          <title>Graphical abstract</title>
          <p>
            <fig id="f0005" position="anchor">
              <graphic xlink:href="fx1"/>
            </fig>
          </p>
        </sec>
        <sec>
          <title>Highlights</title>
          <p>âº The 20-CCPâmodule human protein FH prevents complement-mediated tissue damage. âº NMR structures of CCPs 10â11 and 11â12 suggest that this region enhances flexional strength of FH. âº Concatenating bi-modules helps interpret smallâangle Xâray scattering data, revealing highly compacted arrangement of CCPs 13, 14 and 15. âº Apparent structural dependency of CCP 14 on neighbors could provide a switch between ordered and flexible FH architectures.</p>
        </sec>
      </abstract>
      <kwd-group>
        <title>Abbreviations</title>
        <kwd>CCP, complement control protein</kwd>
        <kwd>CR1, complement receptor type 1</kwd>
        <kwd>DAF, decay accelerating factor</kwd>
        <kwd>FH, factor H</kwd>
        <kwd>EOM, ensemble optimization method</kwd>
        <kwd>HSQC, heteronuclear single quantum coherence</kwd>
        <kwd>MCP, membrane cofactor protein</kwd>
        <kwd>NOE, nuclear Overhauser enhancement</kwd>
        <kwd>SAXS, small-angle X-ray scattering</kwd>
        <kwd>TOCSY, total correlated spectroscopy</kwd>
      </kwd-group>
      <kwd-group>
        <title>Keywords</title>
        <kwd>protein NMR</kwd>
        <kwd>protein domains</kwd>
        <kwd>complement system</kwd>
        <kwd>small-angle X-ray scattering</kwd>
        <kwd>regulators of complement activation</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s0005">
      <title>Introduction</title>
      <p>The activated complement system<xref rid="bb0005 bb0010 bb0015" ref-type="bibr"><sup>1â3</sup></xref> assists in clearance of pathogens in addition to debris from diseased, damaged, dead or dying cells. Hydrolysis of a thioester linkage in complement component C3, yielding C3(H<sub>2</sub>O), is the rare, spontaneous but ubiquitous initiating event of the âalternativeâ pathway of the complement cascade.<xref rid="bb0020" ref-type="bibr"><sup>4</sup></xref> C3(H<sub>2</sub>O) collaborates with proenzyme factor B and proteolytic factor D to create the convertase complex C3(H<sub>2</sub>O).Bb that converts C3 to C3a (an anaphylatoxin) and C3b. C3b is able to rapidly attach covalently to any nearby surface and to form C3b.Bb [a structural and functional analogue of C3(H<sub>2</sub>O).Bb] that, in a positive-feedback loop,<xref rid="bb0025" ref-type="bibr"><sup>5</sup></xref> converts additional C3 to C3b. Particles become coated (âopsonisedâ) with C3b and are then subject to immune clearance. Moreover, C3b participates in both âclassicalâ and âlectinâ pathways; all three pathways feed into the terminal pathway that releases the anaphylatoxin C5a and culminates in the assembly of potentially cytolytic pores.</p>
      <p>Distinction by the alternative pathway between self and nonself is not driven by discriminatory covalent attachment of C3b.<xref rid="bb0020 bb0030" ref-type="bibr"><sup>4,6</sup></xref> Rather, it is accomplished mainly by selective action of factor H (FH), complement receptor type 1 (CR1), membrane cofactor protein (MCP) and decay accelerating factor (DAF).<xref rid="bb0035" ref-type="bibr"><sup>7</sup></xref> Either through being host-membrane bound (CR1, DAF or MCP) or (in the case of FH) via selective association with host-cellâspecific markers,<xref rid="bb0040" ref-type="bibr"><sup>8</sup></xref> these regulators prevent amplification of C3b on self-surfaces. They (DAF, CR1 and FH) perturb formation and stability of C3b.Bb or (CR1, FH and MCP) recruit factor I to cleave C3b, removing it from the amplification loop that continues to operate on, for example, a bacterium. The product, iC3b, cannot form a complex with Bb but remains an opsonin and a ligand for receptors on immune cells.<xref rid="bb0045" ref-type="bibr"><sup>9</sup></xref></p>
      <p>The abundant<xref rid="bb0050" ref-type="bibr"><sup>10</sup></xref> plasma regulator FH (155Â kDa, 1213 residues)<xref rid="bb0055 bb0060" ref-type="bibr"><sup>11,12</sup></xref> fails to adequately protect host tissues from complement-mediated damage over the lifetimes of many individuals who possess <italic>CFH</italic> polymorphisms or mutations.<xref rid="bb0065" ref-type="bibr"><sup>13</sup></xref> Age-related macular degeneration is a prominent example of a disease arising from such a deficiency.<xref rid="bb0070" ref-type="bibr"><sup>14</sup></xref> To explain the molecular bases for these disorders, it is essential to understand why wild-type FH is significantly more active on healthy self-cells than on diseased or foreign ones.<xref rid="bb0075" ref-type="bibr"><sup>15</sup></xref> Moreover, as a self-tissueâspecific regulator of C3 activation, knowledge of the structureâfunction relationships of FH<xref rid="bb0080" ref-type="bibr"><sup>16</sup></xref> could inspire design of therapeutic complement inhibitors useful in the wide range of conditions where complement plays a damaging role.<xref rid="bb0065 bb0085 bb0090 bb0095" ref-type="bibr"><sup>13,17â19</sup></xref></p>
      <p>FH consists entirely of 20 complement control protein (CCP) modules<xref rid="bb0100" ref-type="bibr"><sup>20</sup></xref> of between 51 and 62 residues each, connected by linking sequences of between 3 and 8 residues in length<xref rid="bb0105 bb0110" ref-type="bibr"><sup>21,22</sup></xref> (<xref rid="f0010" ref-type="fig">Fig. 1</xref>). Successful crystallization of FH has not been reported. Current structural knowledge draws on data from small-angle X-ray scattering (SAXS), analytical ultracentrifugation and electron microscopy<xref rid="bb0115 bb0120 bb0125 bb0130" ref-type="bibr"><sup>23â26</sup></xref> combined with high-resolution structures for short discontinuous segments of the protein.<xref rid="bb0135 bb0140 bb0145 bb0150 bb0155 bb0160 bb0165 bb0170 bb0175 bb0180" ref-type="bibr"><sup>27â36</sup></xref></p>
      <p>The N-terminal CCPs 1â4 and the C-terminal CCPs 19â20 of FH bind C3b at adjacent, nonoverlapping sites.<xref rid="bb0170 bb0185 bb0190" ref-type="bibr"><sup>34,37,38</sup></xref> Like full-length FH, a recombinant fragment consisting solely of CCPs 1â4 (i.e., FH 1â4) not only competes with binding of factor B to C3b in solution but also recruits factor I.<xref rid="bb0195 bb0200 bb0205 bb0210" ref-type="bibr"><sup>39â42</sup></xref> In addition, FH has sites within CCPs 6â8 and CCPs 19â20 that interact with polyanionic self-surface markers and are critical for specificity.<xref rid="bb0185 bb0215 bb0220 bb0225 bb0230" ref-type="bibr"><sup>37,43â46</sup></xref> Nearly all disease-linked sequence variations occur at these C3b-binding or polyanion-binding regions of FH<xref rid="bb0065" ref-type="bibr"><sup>13</sup></xref> in which CCPs adopt extended end-to-end arrangements connected by linkers of three or four residues. The central modules of FH (CCPs 9â18), on the other hand, do not contain strong binding sites for polyanions or C3b.<xref rid="bb0185" ref-type="bibr"><sup>37</sup></xref> Thus, tethering together the two C3b/polyanion-binding sites, CCPs 1â8 and CCPs 19â20, might produce an efficient biopharmaceutical.<xref rid="bb0235" ref-type="bibr"><sup>47</sup></xref> However, knowledge on the role of the intervening 10 modules of FH that are hypothesized to enhance the specificity of FH for self-surface protection is lacking.</p>
      <p>This central region has long interâmodular linkers (6, 6, 8, 7 and 5 residues for CCPs 10â11, 11â12, 12â13, 13â14 and 14â15, respectively) (<xref rid="f0010" ref-type="fig">Fig.Â 1</xref>), relatively small modules (51 residues in CCP 13), and accommodates seven of eight utilized N-glycosylation sites in FH.<xref rid="bb0240" ref-type="bibr"><sup>48</sup></xref> Initial notions that CCPs 9â18 merely form a flexible tether between C3b-binding and polyanion-recognition regions were disproved by studies of FH 10â15.<xref rid="bb0175" ref-type="bibr"><sup>35</sup></xref> This molecule failed to crystallize, but a SAXS-derived structural model guided by an NMR-derived FH 12â13 structure was created. The FH 10â15 construct forms a compact rather than flexible or elongated structure.</p>
      <p>Here, we describe recombinant production of the remaining bi-modules (i.e., besides FH 12â13) from the FH 10â15 region and their structural investigation. While samples of FH 13â14 and FH 14â15, unusually for CCP bi-modules, resisted all attempts at preparation in our hands, structures of FH 10â11 and FH 11â12 were readily determined by NMR. A structure of FH 10â12, produced by combining these two high-resolution solution structures, was validated by SAXS. A subsequently constructed model of FH 10â13 allowed reinterpretation of SAXS data for FH 10â15 and FH 8â15. It seems that CCPs 13â15 are compacted, while CCP 14 appears unstable unless it is folded back along CCPs 12 and 13. These possibilities are discussed in terms of the mechanism of FH.</p>
    </sec>
    <sec sec-type="results" id="s0010">
      <title>Results</title>
      <sec id="s0015">
        <title>FH 10â11 and FH 11â12, but not FH 13â14 or FH 14â15, yielded assignable NMR spectra</title>
        <p>We set out to investigate whether the large tilt angle (~Â 80Â°) previously observed between CCPs 12 and 13<xref rid="bb0175" ref-type="bibr"><sup>35</sup></xref> is a consistent feature across the central segment of FH. Like FH 12â13, samples of FH 10â11 and FH 11â12 were straightforward to prepare. Moreover, they gave [<sup>1</sup>H,<sup>15</sup>N]heteronuclear single quantum coherence (HSQC) spectra of high quality with the expected numbers of wellâdispersed cross-peaks (<xref rid="f0015" ref-type="fig">Fig.Â 2</xref>a and b) for stably folded proteins.</p>
        <p>Other overlapping bi-modules within the FH 10â15 regionâFH 13â14 and FH 14â15âproved intractable. Recombinant FH 13â14 was prone to proteolysis and self-association; nevertheless, a <sup>15</sup>N-labeled sample eluting as a monomeric species was obtained from a calibrated size-exclusion chromatography column and produced a single band, of the expected size, by sodium dodecyl sulfateâpolyacrylamide gel electrophoresis. Unexpectedly, this FH 13â14 sample must have been improperly folded since, under a range of conditions, it yielded [<sup>1</sup>H,<sup>15</sup>N]HSQC spectra (<xref rid="ec0005" ref-type="supplementary-material">Supplementary Fig. S1</xref>) dominated by overlapped, broad cross-peaks. An overlay of this spectrum with a [<sup>1</sup>H,<sup>15</sup>N]HSQC spectrum of FH 13 (previously expressed as an isolated module<xref rid="bb0175" ref-type="bibr"><sup>35</sup></xref>) showed that only a few weak cross-peaks from compactly folded CCP 13 could be detected in the CCP 13â14 spectrum (<xref rid="ec0005" ref-type="supplementary-material">Supplementary Fig. S1</xref>). In the case of FH 14â15, no sample suitable for NMR data collection could be prepared due to excessive propensity for proteolysis and oligomerization.</p>
      </sec>
      <sec id="s0020">
        <title>Modules 10â12 do not form a highly elongated structure</title>
        <p>SAXS curves were collected for FH 10â11, FH 11â12 and FH 10â12; neither FH 13â14 nor FH 14â15 samples were suitable. Analysis of parameters extracted from scattering profiles and real-space distance distribution functions, <italic>p</italic>(<italic>r</italic>), reveals monomers (<xref rid="f0020" ref-type="fig">Fig.Â 3</xref> and <xref rid="t0005" ref-type="table">TableÂ 1</xref>) consistent with their elution volumes from size-exclusion chromatography columns. Bi-modules FH 10â11 and FH 11â12 yielded similar radii of gyration (<italic>R</italic><sub>g</sub>) and maximum particle dimensions (<italic>D</italic><sub>max</sub>), but FH 11â12 (<italic>R</italic><sub>g</sub>Â =Â 2.4Â nm and <italic>D</italic><sub>max</sub>Â =Â 8.3Â nm) was slightly more extended than FH 10â11 (<italic>R</italic><sub>g</sub>Â =Â 2.2Â nm and <italic>D</italic><sub>max</sub>Â =Â 7.5Â nm). The positively skewed <italic>p</italic>(<italic>r</italic>) functions of both bi-modules are characteristic of dumbbell-shaped structures; the first maximum represents a common average intra-module distance (~Â 1.7Â nm), and the second maximum represents an approximate average separation of the centers of mass of the two CCPs (~Â  3.8Â nm). Studies of tri-modular FH 10â12 yielded only a modest 0.1â to 0.3ânm increase in <italic>R</italic><sub>g</sub> and 0.8â to 1.2ânm increase in <italic>D</italic><sub>max</sub> (<xref rid="f0020" ref-type="fig">Fig.Â 3</xref> and <xref rid="t0005" ref-type="table">TableÂ 1</xref>). The <italic>p</italic>(<italic>r</italic>) function of FH 10â12 shows a shift in the position of the first maximum relative to that of bi-modules; this reflects an increase in effective cross-section upon addition of the third CCP. These observations clearly demonstrate that FH 10â12 does not have an elongated structure similar to FH 1â3<xref rid="bb0165" ref-type="bibr"><sup>33</sup></xref> or FH 6â8.<xref rid="bb0160" ref-type="bibr"><sup>32</sup></xref></p>
      </sec>
      <sec id="s0025">
        <title>Three-dimensional structures of FH 10â11 and FH 11â12</title>
        <p>The NMR spectra (<sup>13</sup>C,<sup>15</sup>N) for FH 10â11 and 11â12 (<xref rid="f0015" ref-type="fig">Fig.Â 2</xref>a and b) enabled near-complete assignment of <sup>1</sup>H, <sup>15</sup>N and <sup>13</sup>C (<xref rid="t0010" ref-type="table">TableÂ 2</xref>). Following manual partial assignment of <sup>15</sup>Nâ and <sup>13</sup>C-filtered nuclear Overhauser enhancement (NOE) spectroscopy spectra, we input a provisional list of NOE assignments into the first of seven CYANA cycles of structure calculations.<xref rid="bb0245" ref-type="bibr"><sup>49</sup></xref> CYANA-derived distance restraints were used for calculations of structures in CNS (<italic>C</italic>rystallography and <italic>N</italic>MR <italic>S</italic>ystem).<xref rid="bb0250" ref-type="bibr"><sup>50</sup></xref> The 20 lowest-energy CNS-derived structures converged well and were refined in explicit aqueous solvent (<xref rid="f0025" ref-type="fig">Fig.Â 4</xref>a and b; <xref rid="t0010" ref-type="table">TableÂ 2</xref>). Note (as discussed further below) that near-identical structures resulted from a calculation that incorporated both NOEs and SAXS-derived parameters.</p>
        <p>The Î²-strand-rich structures of CCPs 10, 11 and 12 (<xref rid="f0025" ref-type="fig">Fig.Â 4</xref>c and d) contain Cys(I)âCys(III) and Cys(II)âCys(IV) disulfides. The consensus Trp is buried in the cores of CCPs 11 and 12; a Leu occupies this position in CCP 10. STRIDE-identified<xref rid="bb0255" ref-type="bibr"><sup>51</sup></xref> Î²-strands were labeled (in <xref rid="f0025" ref-type="fig">Fig.Â 4</xref>c and d) according to a convention recognizing the occurrence of maximally eight Î²-strands (AâH), at conserved positions, within CCP structures.<xref rid="bb0145 bb0260" ref-type="bibr"><sup>29,52</sup></xref> Slowly exchanging amide protons (<xref rid="ec0005" ref-type="supplementary-material">Supplementary Fig. S2</xref>) coincided with either burial or engagement in hydrogen bonds; after 15Â min of D<sub>2</sub>O exposure, the following numbers of HSQC cross-peaks remained: 2 in CCP 10 and 22 in CCP 11 (none in the linker) for FH 10â11, and 17 in CCP 11 and 9 in CCP 12 (1 in the linker) for FH 11â12. Although CCP 10 has more extensive Î²-strands, CCPs 11 and 12 have more slowly exchanging amides.</p>
        <p>Structures of CCP 10 or 11 converged well when the ensemble of NOE-derived FH 10â11 structures was overlaid solely on either module; CCP 11 or 12 within the FH 11â12 ensemble likewise converged well on a per-module basis (<xref rid="f0025" ref-type="fig">Fig.Â 4</xref>a and b). The structure of CCP 11 from FH 10â11 overlaid well with the structure of CCP 11 from the FH 11â12 structure; moreover, CCP 12 solved in the current work overlaid well on CCP 12 from FH 12â13 (<xref rid="ec0005" ref-type="supplementary-material">Supplementary Fig. S3 and Table S1</xref>). That module structures were conserved in FH 10â11, FH 11â12 and FH 12â13 endorsed construction of models of longer FH segments by concatenating bi-module structures (see below). While CCP 10's structure does not resemble the structures of other FH CCPs (backbone rmsdÂ &gt;Â 2Â Ã; <xref rid="ec0005" ref-type="supplementary-material">Table S1</xref>), it is similar to MCP CCP 3<xref rid="bb0265" ref-type="bibr"><sup>53</sup></xref> (<xref rid="ec0005" ref-type="supplementary-material">Supplementary Fig. S4a</xref>). CCP 12 is very similar in structure to CCP 2 of complement receptor type 2<xref rid="bb0270" ref-type="bibr"><sup>54</sup></xref> (<xref rid="ec0005" ref-type="supplementary-material">Supplementary Fig. S4b</xref>). FH CCPs 11 and 12 resemble one another and are similar to FH CCPs 18 and 19<xref rid="bb0180" ref-type="bibr"><sup>36</sup></xref> (<xref rid="ec0005" ref-type="supplementary-material">Supplementary Fig. S4c and Table S1</xref>).</p>
      </sec>
      <sec id="s0030">
        <title>NOE-derived structures are not under-restrained or over-restrained</title>
        <p>Within each bi-module, ~Â 120 NOEs were identified between modules and their linker (<xref rid="t0010" ref-type="table">TableÂ 2</xref>). Eight NOEs were found directly between CCPs 10 and 11, compared to 38 NOEs between CCPs 11 and 12; thus, a network of NOEs that was more extensive for FH 11â12 than FH 10â11 defines the inferred inter-modular orientations. Indeed, the FH 10â11 structures exhibited good convergence when overlaid over both modules, and a comparable result was obtained for FH 11â12. Moreover, relaxation data (<xref rid="ec0005" ref-type="supplementary-material">Supplementary Fig. S5</xref>) showed that interâmodular linkers are not more mobile than other extended regions of the polypeptide. Nonetheless, several further steps were taken to check that these FH 10â11 and FH 11â12 solution structures were neither over-restrained nor under-restrained.</p>
        <p>First, bi-module structures were recalculated using an ensemble-based simulated annealing protocol (in Xplor-NIH).<xref rid="bb0275 bb0280" ref-type="bibr"><sup>55,56</sup></xref> This allows simultaneous generation of an ensemble of <italic>n</italic> conformers that, between them, satisfy all NOE-derived distance restraints. With the use of an ensemble size (<italic>n</italic>) of 2, ensemble members turned out to be nearly identical with one another and to the outcome of a standard simulated annealing protocol (i.e., effectively, <italic>n</italic>Â =Â 1); thus, we found no evidence that FH 10â11 or FH 11â12 adopts multiple conformers interconverting on the NOE timescale.</p>
        <p>Second, NOE (only)-derived structures of FH 10â11 were fit to the FH 10â11 SAXS data (using CRYSOL<xref rid="bb0285" ref-type="bibr"><sup>57</sup></xref>) with discrepancies (Ï) (between data and model) of 1.3â1.6; equivalent values for FH 11â12 were 1.6â2.2 (<xref rid="ec0005" ref-type="supplementary-material">Supplementary Fig. S6a</xref>). Thus, for both bi-modules, the NMR-derived structures provide a good fit to the scattering data. Furthermore, in an <italic>ab initio</italic> approach, the average structures of both bi-modules were reconstructed from SAXS data (using DAMMIF<xref rid="bb0290" ref-type="bibr"><sup>58</sup></xref>). Within each set of 10 independent reconstructions, highly similar shapes were obtained, with low (&lt;Â 1.0) normalized spatial discrepancies.<xref rid="bb0295" ref-type="bibr"><sup>59</sup></xref> Importantly, discrepancies between these models and high-resolution NMR-derived structures were small (ÏÂ =Â 0.9â1.2) in both cases. When averaged and volume-fitted <italic>ab initio</italic> shapes were superimposed with the corresponding NMR ensembles using SUPCOMB,<xref rid="bb0295" ref-type="bibr"><sup>59</sup></xref> good spatial agreement was observed (<xref rid="ec0005" ref-type="supplementary-material">Supplementary Fig. S6b</xref>), thus validating the NMR-derived structures.</p>
        <p>Finally, structure calculations (with ensemble sizes of 1 and 2) were conducted for each bi-module with incorporation of both NOE and SAXS data<xref rid="bb0300" ref-type="bibr"><sup>60</sup></xref> as experimental structural restraints.<xref rid="bb0305" ref-type="bibr"><sup>61</sup></xref> These calculations yielded structures (<xref rid="ec0005" ref-type="supplementary-material">Table S2</xref>) that were nearly identical with NOE-only structures and exhibited no NOE violationsÂ &gt;Â 0.5Â Ã.</p>
      </sec>
      <sec id="s0035">
        <title>CCPs 11 and 12 are more intimately associated than CCPs 10 and 11</title>
        <p>Bi-modules FH 10â11 and FH 11â12 are bent (or tilted) by ~Â 118Â° and ~Â 90Â°, respectively, away from a linearly extended form. The surface area effectively buried between the N-terminal (CCP 10) and the C-terminal (CCP 11) halves of FH 10â11 (using the peptide bond between the middle two residues of the linker as a boundary) is only ~Â 360Â Ã<sup>2</sup>, consistent with detection of just eight NOEs between these modules. An inferred salt bridge (<xref rid="ec0005" ref-type="supplementary-material">Supplementary Fig. S7</xref>) links the first residue of the linker (Lys624, the last residue of CCP 10 Î²-strand H) to Asp675 of the CCP 11 FG Î²-turn. Residues Thr602 and Val604 from the CCP 10 Î²-strand E (paired with CCP 10 Î²-strand H) participate in interâmodular van der Waals contacts with CCP 11 residues His651 and Asp675 (in BD loop and FG Î²-turn, respectively). All four contribute, along with alkyl portions of linker residues Lys624, Val627 and Gln628, to a hydrophobic pocket wedged between the modules (<xref rid="f0030" ref-type="fig">Fig.Â 5</xref>a). Polar side chains of linker residues Glu625, Gln626 and Ser629 are solvent exposed on the convex surface of the inter-modular bend.</p>
        <p>In FH 11â12, side chains of the DE loop and Î²-strand E of CCP 11 (Pro661, Arg662, Phe663 and Leu664) make extensive van der Waals interactions with alkyl portions of linker residues (while polar portions are displayed on the convex surface of the bend) and with a segment of the BD loop of CCP 12 (Tyr710, Tyr711 and Gly712) (<xref rid="f0030" ref-type="fig">Fig.Â 5</xref>b). All these side chains are substantially buried in a hydrophobic pocket significantly bigger than the equivalent pocket in FH 10â11âthe surface area buried between modules 11 and 12 is ~Â 640Â Ã<sup>2</sup>.</p>
        <p>In summary, CCPs 11 and 12 are welded together at an ~Â 90Â° tilt in the structure calculation by a substantial number of mutually compatible NOEs reflecting extensive interactions and burial of a sizeable surface area. Modules 10 and 11 are mutually orientated at an even greater bend angle to accommodate (NOE-supported) interactions between strand E of CCP 10 and the CD and FG loops of CCP 11. Only a small surface area is buried between CCPs 10 and 11, but a Lys624âAsp675 salt bridge may stabilize it.</p>
      </sec>
      <sec id="s0040">
        <title>FH 10â12 can be modeled from SAXS data and concatenation of bi-modules</title>
        <p>Samples of FH 10â12 did not yield NMR spectra suitable for structure determination. This problem, encountered in previous efforts to solve triple-CCPâmodule structures,<xref rid="bb0165 bb0260" ref-type="bibr"><sup>33,52</sup></xref> was ascribed to anisotropic tumbling yielding lower <italic>T</italic><sub>2</sub> values than a globular protein of comparable mass. Broad peaks and crowded spectra precluded identification of sufficient inter-modular and module-to-linker NOEs without more elaborate isotopic labeling. Nonetheless, FH 10â12 yielded useful SAXS data. Three methods were used to combine results of SAXS for FH 10â12 and NMR for FH 10â11 and FH 11â12.</p>
        <p>First, a model of FH 10â12 built by concatenating FH 10â11 and FH 11â12 structures (<xref rid="f0035" ref-type="fig">Fig.Â 6</xref>a and b) was validated on the basis of successful fitting to SAXS data for FH 10â12 (ÏÂ =Â 0.8) (<xref rid="f0035" ref-type="fig">Fig.Â 6</xref>c) using the same method (see above) as employed for bi-modules. Second, in an <italic>ab initio</italic> approach, also similar to that described for the bi-modules, the average solution structure of FH 10â12 was reconstructed from SAXS data. As with the bi-modules, independent reconstructions yielded similar shapes (average normalized spatial discrepanciesÂ =Â 0.73Â Â±Â 0.12), while discrepancies between models and experimental data were low (ÏÂ =Â 0.88Â Â±Â 0.01), whereas the total excluded dummy-atom volume of the model matched the expected monomeric molecular mass. Encouragingly, the average <italic>ab initio</italic> shape superimposed well with, and thereby validated, the concatenated NMR model of FH 10â12 (<xref rid="ec0005" ref-type="supplementary-material">Supplementary Fig. S2b</xref>). Finally, a combined FH 10â12 NOE list was compiled by concatenating FH 10â11 and FH 11â12 NOEs in a way that eliminated duplication or conflict of NOEs originating from the mutual CCP 11. Then, FH 10â12 structures were calculated using simulated annealing, employing as restraints both SAXS data and the combined NOE list. As with bi-modules, ensembles (<italic>n</italic>Â =Â 1 or 2) of structures were derived, with energy terms calculated as ensemble averages. Calculated FH 10â12 structures were in good agreement with the concatenated model, with each other and with both NOE and SAXS data.</p>
        <p>The ensemble optimization method (EOM)<xref rid="bb0310" ref-type="bibr"><sup>62</sup></xref> was used to investigate flexibility of FH 10â12. In an initial application, NMR-derived structures of individual CCPs 10, 11 and 12 were used as rigid bodies and linker regions defined as flexible chains of dummy atoms to generate a pool of random conformations. Sets of conformers from the pool whose combined theoretical scattering pattern best fit the experimental data were then selected and compared to the whole pool of conformers. The size distribution of the selected ensemble (<xref rid="f0040" ref-type="fig">Fig.Â 7</xref>a) was narrower than that of the random pool and skewed toward compact conformations. Thus, the results of the EOM analysis are consistent with rigidity of modular connections and FH 10â12 not being significantly flexible or particularly extended. A subsequent EOM iteration was based on the observation of significantly fewer NOEs between CCPs 10 and 11 than between CCPs 11 and 12. Thus, CCPs 11 and 12 along with their linker were defined as a rigid body, while the 10â11 linker was treated as flexible. The resulting narrow size distribution (<xref rid="f0040" ref-type="fig">Fig.Â 7</xref>b) of the selected ensemble suggests that the CCP 10â11 linker is not significantly flexible in the FH 10â12 context, notwithstanding the relatively small surface area buried between modules.</p>
      </sec>
      <sec id="s0045">
        <title>Structure of FH 10â13 and reinterpreting SAXS data for FH 10â15 and FH 8â15</title>
        <p>FH 10â11, FH 11â12 and FH 12â13<xref rid="bb0175" ref-type="bibr"><sup>35</sup></xref> are all relatively rigid, and FH 10â12 lacks significant flexibility. Thus, interâmodular angles are likely to be preserved between bi-module and tetra-module contexts. Hence, a concatenated model of FH 10â13âbased on the three bi-module structuresâshould be reliable. MODELLER was used to construct such a model (<xref rid="f0045" ref-type="fig">Fig.Â 8</xref>), which shows how the curvature of FH 10â11 does not follow the arc described by FH 11â13, resulting in an out-of-plane zigzag structure. This model allowed reinterpretation of previously analyzed SAXS data for FH 10â15 and FH 8â15 with a less ambiguous outcome. Given that sequence directionality can be reliably inferred on the basis of the concatenated model of FH 10â13, rigid-body refinement of FH 10â15 consistently yields conformations with a compact C-terminal structure (<xref rid="f0045" ref-type="fig">Fig.Â 8</xref>); in these conformations, CCPs 14 and 15 interact intimately with CCP 13, which could have functional implications for the regulation of complement by FH as discussed below.</p>
        <p>To assess the effect of adding CCPs 8 and 9 to FH 10â15, we conducted EOM analysis on FH 8â15. Lacking information to the contrary, all linkers excluding CCPs 10â11, 11â12 and 12â13 were defined as flexible. It was found that significant populations of both extended and compact inter-modular linker conformations were required in order to fit the data, resulting in a broad and bi-modal population distribution (<xref rid="f0040" ref-type="fig">Fig.Â 7</xref>c). Assuming that the FH 10â15 core remains rigid in the context of FH 8â15, this observation implies that CCPs 8 and 9 are not tightly associated with the other six modules. Interestingly, both SAXS data (<xref rid="f0020" ref-type="fig">Fig.Â 3</xref>) and a [<sup>1</sup>H,<sup>15</sup>N]HSQC spectrum collected on recombinant FH 8â9 (data not shown) indicated that this bi-module is as well folded as CCP 11â12 or 12â13. In conclusion, structurally autonomous CCPs 8 and 9 (connected to each other and to CCP 10 with wellâconserved linkers) adopt a much less intimate association with CCPs 10â13 than do CCPs 14 and 15; this observation supports the idea that the variable 13â14 linker and structural dependency of CCP 14 on its neighbors impose a uniquely compact arrangement of CCPs 14 and 15 with CCPs 10â13.</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="s0050">
      <title>Discussion</title>
      <p>Like all known CCP structures<xref rid="bb0315" ref-type="bibr"><sup>63</sup></xref> (except CCP 13<xref rid="bb0175" ref-type="bibr"><sup>35</sup></xref>), CCPs 10, 11 and 12 approximate to flattened prolate spheroids in which N and C termini occupy opposite poles. Given relatively small cross-sectional areas at intersections with neighbors, there are limited ways in which a long string of CCPs (such as FH) could attain the level of rigidity presumably needed for functional cooperation between remote binding sites. The two N-terminal modules of complement receptor type 2, for example, exhibit side-by-side interactions because the eight-residue inter-modular linker is long enough to allow a 142Â° interâmodular bend (away from linearity).<xref rid="bb0270" ref-type="bibr"><sup>54</sup></xref> The rod-like architecture of FH CCP 19â20, on the other hand, arises from its minimal three-residue linker that restricts tilt and ensures interactions between loops on neighboring modules so as to also limit twist.<xref rid="bb0150 bb0155" ref-type="bibr"><sup>30,31</sup></xref></p>
      <p>In the current work on FH 10â11, FH 11â12 and FH 10â12, we describe two CCPâCCP junctions that encompass six-residue inter-modular linkers. By working in solution, we minimized the risk for observation of potentially anomalous inter-modular tilts such as that observed between CCPs 18 and 19 in the crystal structure of FH 18â20.<xref rid="bb0180" ref-type="bibr"><sup>36</sup></xref> By combining NMR and SAXS, we circumvented the need for measurements of residual dipolar couplings wherein interaction with alignment media carries a theoretical risk of perturbing interâmodular angles or dynamics. The relatively long linkers among CCPs 10, 11 and 12 facilitate large tilts and consequently significant inter-module interactions; their side chains also contribute to the hydrophobic âglueâ between adjacent modules. A broadly similar arrangement of modules occurs in FH 12â13.<xref rid="bb0175" ref-type="bibr"><sup>35</sup></xref> Although previous SAXS-based studies of FH 1â5, FH 6â8 and FH 16â20 also indicated bent-back structures,<xref rid="bb0130" ref-type="bibr"><sup>26</sup></xref> high-resolution studies showed FH CCPs 1â3,<xref rid="bb0165 bb0170" ref-type="bibr"><sup>33,34</sup></xref> FH 6â8<xref rid="bb0160" ref-type="bibr"><sup>32</sup></xref> and CCPs 19â20<xref rid="bb0180 bb0235 bb0320" ref-type="bibr"><sup>36,47,64</sup></xref> to be linear or gently curved. Thus, overlapping bi-modules FH 10â11, FH 11â12 and FH 12â13, connected by linkers of six or eight residues and with tilts of about 80â100Â°, represent the most strongly tilted succession of four CCPs described to date. The FH conformation is ionic strength dependent and pH sensitive<xref rid="bb0325" ref-type="bibr"><sup>65</sup></xref>; it is thus worth noting that equivalent His side chains (His651 in FH 11 and His773 in FH 13) feature prominently in both FH 10â11 and FH 12â13 interfaces while a salt bridge, Lys624âAsp675, may stabilize the small FH 10â11 junction.</p>
      <p>That all three bi-modules exhibit only limited interâmodular flexibility is consistent with the notion that the middle portion of the FH molecule needs flexional reinforcement if the ends (that carry the binding sites) are to be held in (one or more) preferred juxtaposition(s). An assumption that the inter-modular angles observed in the bi-modules 10â11 and 11â12 would persist in the tri-module FH 10â12 was validated by SAXS analysis. Therefore, it was reasonable to concatenate the three bi-modules to reconstruct CCPs 10â13, thus allowing us to trace the path in space of four modules within the central portion of FH. In agreement with a previous analysis of SAXS data for FH 10â15, CCPs 10â13 in this model do not all bend in the same direction to form a horseshoe-like shape. Instead, they form an out-of-plane S-shape or zigzag because the CCP 10â11 bend does not follow the curvature of CCPs 11â13.</p>
      <p>We could not extend this instructive NMR-supported exercise to CCPs 14 and 15, as it was impossible to prepare the requisite samples of FH 13â14 or FH 14â15. No suitably stable samples were produced despite repeated attempts to exploit approaches that had previously proved successful for numerous CCP module pairs and longer constructs. This may be a host-specific effect; for example, low stability may arise from the lack of appropriate N-glycosylation<xref rid="bb0330" ref-type="bibr"><sup>66</sup></xref> or the presence of a site in folded CCP 14 that is uniquely susceptible to a <italic>Pichia pastoris</italic> protease despite addition of protease inhibitors. Nonetheless, several strands of evidenceâdescribed belowâsuggest that this finding in fact reflects a structural dependency of the common module, that is, CCP 14, on one or more immediate neighbors. Stabilizing interactions between CCP modules were noted in several previous studies,<xref rid="bb0335 bb0340" ref-type="bibr"><sup>67,68</sup></xref> and there are two reports of strand swapping between neighboring CCP modules<xref rid="bb0345 bb0350" ref-type="bibr"><sup>69,70</sup></xref>; moreover, a non-compactly folded CCP module was discovered in the GABA<sub>B</sub> receptor.<xref rid="bb0355" ref-type="bibr"><sup>71</sup></xref> Thus, instability of CCP 14 in the absence of neighboring modules would not be unprecedented.</p>
      <p>In previous SAXS-based studies of FH 10â15, one of two molecular models that fitted the experimental data featured CCP 14 folded back over CCP 13 with extensive, potentially mutually stabilizing, interactions between modules.<xref rid="bb0175" ref-type="bibr"><sup>35</sup></xref> The new solution structures of FH 10â11 and FH 11â12 allow a clearer interpretation of the FH 10â15 SAXS data; importantly, they reinforce the case for a near-180Â° bend between CCPs 13 and 14. Indeed, in the reinterpreted SAXS and NMR-based model of FH 10â15, CCP 14 contacts not only CCP 13 but also the 12â13 linker (<xref rid="f0045" ref-type="fig">Fig.Â 8</xref>). In the model, CCP 15 also contacts both the 12â13 linker and CCP 13. Notably, recombinant versions of single-module FH 13 and FH 15, but not FH 14, were readily prepared, yielding excellent NMR spectra. Moreover, relative well-behaved samples of FH 11â14, FH 10â15,<xref rid="bb0175" ref-type="bibr"><sup>35</sup></xref> FH 15â18 and FH 15â19<xref rid="bb0235" ref-type="bibr"><sup>47</sup></xref> also proved relatively straightforward to prepare. We were additionally able to prepare unlabeled NMR samples of the tri-module FH 13â15 although the quality of the <sup>1</sup>H NMR spectrum was inferior to that of other tri-modules.<xref rid="bb0175" ref-type="bibr"><sup>35</sup></xref></p>
      <p>Taking all these observations together implies that, for full stability, CCP 14 requires a stabilizing interface with CCPs 12, 13 and 15. On the other hand, CCPs 13 and 15 do not require CCP 14 (or CCP 12) for stability; rather, based on the lack of appropriate cross-peaks in the HSQC spectrum of FH 13â14, the attachment of putatively disordered CCP 14 to CCP 13, in the module-pair context, actually destabilizes CCP 13. Its highly conserved sequence is not suggestive of CCP 14 being unusual. Indeed, metaPrDOS<xref rid="bb0360" ref-type="bibr"><sup>72</sup></xref> does not predict a disordered structure for the CCP 14 sequence. On the other hand, its interface with CCP 13 must indeed be irregular. First, the 13â14 linker is the most variable (between orthologues) of any region within the whole of FH; for example, the CCP 13â14 linker is TSKTS in mice and NEEAKIQL in cows. All other 18 linkers are highly conserved. It is also the only linker of human FH that forms part of an occupied N-glycosylation sequence. Second, CCP 13 is poorly conserved in sequence across orthologues. Third, CCP 13 is less elongated than other CCPs andâimportantlyâlacks the DE loop and Î²-strand H that normally help to form a stable end-to-end interface with a subsequent CCP. By contrast, CCPs 8 and 9 that are structurally independent, have (or are predicted to have in the case of CCP 9<xref rid="bb0315" ref-type="bibr"><sup>63</sup></xref>) classical CCP structures and are connected to each other and CCP 10 by conserved linkers are flexibly associated with the FH 10â13 unit.</p>
      <p>Despite the low resolution of the NMR and SAXS-derived model of CCPs 10â15, it is highly plausible. According to the model, CCPs 12, 13, 14 and 15 form a compact structural unit unlike any other region of FH that has been described to date. CCPs 10, 11, 12 and 13 follow a more open zigzag path with 90Â° tilts (see <xref rid="f0045" ref-type="fig">Fig.Â 8</xref>). CCPs 12 and 13 act as a bridge between these two structural regions of FH 10â15 by participating in both of them. The linker between CCPs 13 and 14 is very probably unique in the FH molecule in that it has no structural role but forms a flexible and exposed loop on its surface. The positioning of CCP 13 in this model and the fact that CCP 14 is tilted away, leaving the C-terminal end of CCP 13 free, expose not only the non-conserved 13â14 linker but also an extensive highly variable region of CCP 13 encompassing Î²-strand B and the long BC loop (that includes a helical insertion), the variable DE loop and the aforementioned (non-conserved) N-glycosylation sequon adjacent to the C-terminal cysteine. Note that the presence within the central region of FH of large tilt angles or kinks is consistent, both with best-fit models from SAXS studies<xref rid="bb0125" ref-type="bibr"><sup>25</sup></xref> and with earlier transmission electron micrographs of full-length FH.<xref rid="bb0120" ref-type="bibr"><sup>24</sup></xref></p>
      <p>While the sequential series of interâmodular tilts between CCPs 10 and 13 contribute to flexional reinforcement, the purpose of an extreme tilt at 13â14 is less clear. Further studies would be needed to investigate whether this module pair could correspond to the âhingeâ in FH that has been suggested<xref rid="bb0175" ref-type="bibr"><sup>35</sup></xref> as a means whereby the molecule can switch rapidly between two conformationsâa compact or closed one (as reflected in FH 10â15) that holds the two binding sites in such a way that they have relatively low affinity for C3b<xref rid="bb0365" ref-type="bibr"><sup>73</sup></xref> and an âopenâ one in which the two ends are able to bind simultaneously, and with high affinity, to nonoverlapping sites on a single molecule of C3b (or adjacent C3b molecules) in the context of a self-surface and its polyanionic markers. More investigation is required to test whether flexional stress or exposure to the electronegative environment found at the host surface disrupts the 13â14 interface. Under these circumstances, module 14 would be likely to become intrinsically disordered, creating a very flexible segment within the FH molecule and allowing terminal regions to cooperate in binding to a target.</p>
    </sec>
    <sec sec-type="materials|methods" id="s0055">
      <title>Materials and Methods</title>
      <sec id="s0060">
        <title>Protein production</title>
        <p>Using procedures similar to those previously described,<xref rid="bb0150 bb0370" ref-type="bibr"><sup>30,74</sup></xref> we produced recombinant proteins in <italic>P. pastoris</italic>. Very briefly, DNA encoding FH 10â11 (amino acid residues 566â687), FH 11â12 (amino acid residues 627â747), FH 10â12 (amino acid residues 566â745), FH 13â14 (amino acid residues 748â865) or FH 14â15 (amino acid residues 808â929) (numbers refer to unprocessed initial human gene product) was PCR amplified from FH cDNA. Each insert was ligated into a TOPO plasmid vector subsequently used to transform Top10 <italic>Escherichia coli</italic> cells (Invitrogen). The amplified plasmid was digested (PstI and XbaI), and target DNA was ligated into the pPICZÎ± B vector (Invitrogen), 3â² of DNA coding for the <italic>Saccharomyces cerevisiae</italic> Î±-mating factor secretion signal that directs protein production into the secretory pathway. Following amplification in <italic>E. coli</italic> cells and SacI linearization, we used the plasmid to transform <italic>P. pastoris</italic> KM71H. Transformed yeast cells were fermented, and gene expression was induced with methanol. Following centrifugal cell removal, we undertook purification from media using ion-exchange chromatography, typically on SP-Sepharose (GE Healthcare), normally followed by size-exclusion chromatography on a Hi-Load 16/60 Superdex 75 120-mL column (GE Healthcare). Proteins bearing high-mannose N-linked glycans were treated (after first purification step) with Endo H<sub>f</sub> (New England Biolabs). Purification was monitored by sodium dodecyl sulfateâpolyacrylamide gel electrophoresis under reducing and nonreducing conditions; the molecular weight of the purified material was validated with Fourier transformâion cyclotron mass spectrometry. For <sup>15</sup>N enrichment, cells were grown in minimal media supplemented with <sup>15</sup>N-labeled ammonium sulfate (Isotec, Sigma-Aldrich), glycerol, basal salts, trace elements and vitamins and were subsequently induced with methanol. For <sup>13</sup>C,<sup>15</sup>N enrichment, a similar protocol was used but cells were grown in media containing <sup>13</sup>C glucose (instead of glycerol), and prior to induction with <sup>13</sup>C methanol, <sup>13</sup>C glycerol (Isotec, Sigma-Aldrich) was added to facilitate derepression of the alcohol oxidase promoter.</p>
      </sec>
      <sec id="s0065">
        <title>Collection and processing of NMR data and assignment of spectra</title>
        <p>NMR spectra were collected at 298Â K on samples containing 10% (v/v) D<sub>2</sub>O in 5-mm NMR tubes, on Bruker AMX 800â and 600âMHz instruments fitted with cryoprobes. Gradual proteolysis occurred in the case of FH 10â11, necessitating production of three <sup>13</sup>C,<sup>15</sup>N-labeled NMR samples (at 400, 150 and 500Â Î¼M in 20Â mM potassium phosphate buffer, pHÂ 6.7). For FH 11â12, one 650âÎ¼M <sup>13</sup>C,<sup>15</sup>N-labeled sample (in 20Â mM potassium phosphate buffer, pHÂ 6.3) sufficed. In the case of FH 13â14, production of a properly folded and stable sample suitable for NMR proved difficult (see <xref rid="s0010" ref-type="sec">Results</xref>) and only a <sup>15</sup>N-labeled sample (150Â Î¼M in 20Â mM potassium phosphate buffer, pHÂ 6.6) was prepared. Topspin version 1.3 (Bruker) was used to set up the experiments, to acquire data and for initial data processing. The data were brought to their final format by processing using AZARA (W. Boucher, Department of Biochemistry, University of Cambridge, UK).</p>
        <p>Resonance assignments were accomplished using the CCPN Analysis software.<xref rid="bb0375" ref-type="bibr"><sup>75</sup></xref> For backbone assignments, HBHANH (for FH 11â12), HBHA(CO)NH, CBCANH, CBCA(CO)NH, HNCO and HN(CA)CO experiments were collected. For side-chain assignments, HCCHâtotal correlated spectroscopy (TOCSY), H(C)(CO)NHâTOCSY and (H)C(CO)NHâTOCSY experiments were acquired along with (two-dimensional) (HB)CB(CGCD)HD and (HB)CB(CGCDCE)HE experiments for assigning aromatic side chains.</p>
      </sec>
      <sec id="s0070">
        <title>Solution structure determination</title>
        <p>Including the nonnative N-terminal sequence (EAAG and EAEAAG in FH 10â11 and FH 11â12, respectively), 88% of triple-resonance assignments, including 97% of backbone atoms for FH 10â11 and 88% of triple-resonance assignments, including 95% of backbone atoms for FH 11â12, were completed. Of the theoretically assignable backbone atoms, the following were missing: Pro632 (CO), Pro633 (CO) and Asp675 (N and HN) in the case of FH 10â11 and Glu621 (H, HN, CO, C<sup>Î±</sup>), Ala622 (H, HN and C<sup>Î±</sup>), Pro632 (CO, C<sup>Î±</sup>), Pro633 (CO), Asp675 (N, HN), Pro707 (CO) and Ile747 (CO) in the case of FH 11â12.</p>
        <p>In one out of twelve in the case of FH 10â11 (Pro618) and one out of ten in the case of FH 11â12 (Pro708), X-Pro linkages were defined as <italic>cis</italic>, while the remainder were defined as <italic>trans</italic> as judged by chemical shift differences between Pro <sup>13</sup>C<sup>Î²</sup> and <sup>13</sup>C<sup>Î³</sup> atoms,<xref rid="bb0380" ref-type="bibr"><sup>76</sup></xref> by strong NOEs observed between H<sup>Î±</sup> (Xaa<sup><italic>i</italic>Â âÂ 1</sup>) and H<sup>Î±</sup> (Pro<sup><italic>i</italic></sup>) and between H<sup>Î±</sup> (Xaa<sup><italic>i</italic>Â âÂ 1</sup>) and HN (Xaa<sup><italic>i</italic>Â +Â 1</sup>) and by no or weak detectable NOEs between H<sup>Î±</sup> (Xaa<sup><italic>i</italic>Â âÂ 1</sup>) and H<sup>Î´</sup> (Pro<sup><italic>i</italic></sup>). Based on mass spectrometry, all eight cysteine residues in both FH 10â11 and FH 11â12 were inferred to be in the oxidized state. Specific disulfide bridges were incorporated into the final rounds of structure calculations on the basis of NOEs (reinforced by a precedent established by previous studies of CCPs). Approximately 3% (for FH 10â11) and 14% (for FH 11â12) of peaks in the <sup>15</sup>N-edited NOE spectroscopy spectra were assigned manually while, for both constructs, ~Â 8% of peaks in the <sup>13</sup>C-edited NOE spectroscopy spectra were also assigned manually.</p>
        <p>Remaining NOEs were assigned by a combination of automated assignment and structure calculation. Thus, seven cycles of CYANA 2.1<xref rid="bb0245" ref-type="bibr"><sup>49</sup></xref> were employed for each of FH 10â11 and FH 11â12 to generate lists of NOE-derived distance restraints and sets of preliminary structures. Once CYANA-generated parameters met published quality criteria,<xref rid="bb0245" ref-type="bibr"><sup>49</sup></xref> distance restraints were transferred into the program CNS,<xref rid="bb0250" ref-type="bibr"><sup>50</sup></xref> using the CCPN Format Converter program. Working within CNS allows structure refinement against explicit water.</p>
      </sec>
      <sec id="s0075">
        <title>Assessing and comparing structures</title>
        <p>The quality of structures was assessed using PROCHECK<xref rid="bb0385" ref-type="bibr"><sup>77</sup></xref> (see <xref rid="t0005" ref-type="table">TableÂ 1</xref>). A hydrogenâdeuterium exchange experiment was performed to cross-validate hydrogen bonds observed in the NOE-derived structures; for this purpose, lyophilized protein was transferred to deuterated buffer, whereupon slowly exchanging amide protons were identified in a [<sup>15</sup>N,<sup>1</sup>H]HSQC spectrum collected 15Â min after exposure to D<sub>2</sub>O. Secondary structure elements were identified using STRIDE.<xref rid="bb0255" ref-type="bibr"><sup>51</sup></xref></p>
        <p>The Web server VADAR 1.8<xref rid="bb0390" ref-type="bibr"><sup>78</sup></xref> was used to establish the solvent accessible surface area (Ã<sup>2</sup>); the buried surface area was computed as (SA module<sub><italic>i</italic></sub>Â +Â SA module<sub><italic>j</italic></sub>)Â âÂ SA bi-module<sub><italic>ij</italic></sub>, where CCP <italic>i</italic> was considered to encompass one residue before its Cys(I) and three residues after its Cys(IV), and CCP (<italic>j</italic>) boundaries were considered the third residue before its Cys(I) and one residue after its Cys(IV).</p>
        <p>Interâmodular tilt, twist and skew angles<xref rid="bb0145 bb0395" ref-type="bibr"><sup>29,79</sup></xref> were determined using an in-house script<xref rid="fn0015" ref-type="fn">â </xref>; a vector was chosen between the principal axis of the inertia tensor (the <italic>z</italic>-axis) and the C<sup>Î±</sup> of Leu616 (CCP 10), Trp678 (CCP 11) or Trp738 (CCP 12), respectively, and with module boundaries defined as Cys(I), that is, Cys569 (CCP 10), Cys630 (CCP 11) or Cys691 (CCP 12), and Cys(IV), that is, Cys623 (CCP 10), Cys684 (CCP 11) or Cys744 (CCP 12), respectively.</p>
        <p>Combinatorial extension<xref rid="bb0400" ref-type="bibr"><sup>80</sup></xref> was employed to compare each experimentally determined CCP structure within the complement system against the closest-to-mean individual structures determined herein.</p>
      </sec>
      <sec id="s0080">
        <title>SAXS data collection and interpretation</title>
        <p>Synchrotron radiation X-ray scattering data were collected on the X33 beamline of the European Molecular Biology Laboratory (Deutsches ElektronenâSynchrotron, Hamburg) using a 1M PILATUS pixel detector (Dectris, Switzerland) and eight frames of 15-s exposure time. Samples were analyzed at 20Â Â°C, using protein concentrations of 0.3â10.7Â mg/mL in phosphateâbuffered saline. The sample-to-detector distance was 2.7Â m, covering a range of momentum transfer 0.08Â â¤Â <italic>s</italic>Â â¥Â 6.0Â nm<sup>âÂ 1</sup> [where <italic>s</italic>Â =Â 4Ïsin(Î¸)/Î» , with 2Î¸ being the scattering angle and Î»Â =Â 0.15Â nm being the X-ray wavelength]. Based on comparison of successive 15-s frames, samples in which radiation damage was detected were further scrutinized and only frames showing no significant change in intensity were used for subsequent data analysis.</p>
        <p>Data from the detectors were normalized to the transmitted beam intensity and averaged, and the scattering of buffer solutions was subtracted. The difference curves were scaled for solute concentration. Data manipulations were performed using the ATSAS software package<xref rid="bb0405 bb0410" ref-type="bibr"><sup>81,82</sup></xref> utilizing the recently developed DATTOOL library for averaging, merging and extrapolation to infinite dilution from concentration series (Guinier regions for samples at several concentrations, showing linearity; <xref rid="ec0005" ref-type="supplementary-material">Supplementary Fig. S8</xref>). The forward scattering <italic>I</italic>(0) and radius of gyration <italic>R</italic><sub>g</sub> were determined from Guinier analysis,<xref rid="bb0415" ref-type="bibr"><sup>83</sup></xref> assuming that, at very small angles (<italic>s</italic>Â â¤Â 1.3/<italic>R</italic><sub>g</sub>), the intensity is represented as <italic>I</italic>(<italic>s</italic>)Â =Â <italic>I</italic>(0)exp((<italic>sR</italic><sub>g</sub>)2/3). These parameters were also estimated from the full scattering curves using the indirect Fourier transform method implemented in the program GNOM,<xref rid="bb0420" ref-type="bibr"><sup>84</sup></xref> along with the distance distribution function <italic>p</italic>(<italic>r</italic>) and the maximum particle dimensions <italic>D</italic><sub>max</sub>. Molecular masses of solutes were estimated from SAXS data by comparing the extrapolated forward scattering with that of a reference solution of bovine serum albumin (66Â kDa).</p>
      </sec>
      <sec id="s0085">
        <title>Fit of the NMR structures of FH fragments to the SAXS data</title>
        <p>The fits of the NMR-derived structures of FH fragments to the SAXS data were conducted using the program CRYSOL.<xref rid="bb0285" ref-type="bibr"><sup>57</sup></xref> CRYSOL calculates the partial scattering amplitudes of proteins from their atomic coordinates, taking into account the hydration layer and excluded solvent volume. The number of harmonics was set to 50 and 256 points computed across the entire data range (0Â &lt;Â <italic>s</italic>Â &lt;Â 5Â nm<sup>âÂ 1</sup>). The NMR-derived structures were also fitted to the SAXS data with Xplor-NIH using 500 solid angles and 100 data points evenly distributed in a cubic spline constructed using the SAXS data within the range specified above.<xref rid="bb0425" ref-type="bibr"><sup>85</sup></xref></p>
      </sec>
      <sec id="s0090">
        <title>Analysis of flexibility</title>
        <p>Analysis of inter-module flexibility and size distribution of possible conformers consistent with the measured scattering data was conducted using the EOM.<xref rid="bb0310" ref-type="bibr"><sup>62</sup></xref> The EOM selects an ensemble of possible conformations of input rigid bodies (using the CCP modules 10, 11 and 12 determined in this study and the remaining modules as described previously<xref rid="bb0170" ref-type="bibr"><sup>34</sup></xref>) and userâdefined regions of flexible sequence (here defined as the linkers between CCP modules) from a pool of 10,000 randomly generated models, using CRYSOL to calculate the theoretical scattering profiles and a genetic algorithm, GAJOE, to select the representative set that best describes the experimental data.</p>
      </sec>
      <sec id="s0095">
        <title><italic>Ab initio</italic> shape determination and molecular modeling</title>
        <p>Low-resolutionâshape envelopes were determined using the <italic>ab initio</italic> bead-modeling program DAMMIF.<xref rid="bb0290" ref-type="bibr"><sup>58</sup></xref> DAMMIF represents the particle as a collection of <italic>M</italic> densely packed beads inside an adaptable and loosely constrained search volume compatible with the experimentally determined <italic>R</italic><sub>g</sub>. Each bead is randomly assigned to solvent (indexÂ =Â 0) or solute (indexÂ =Â 1), and the particle structure in solution is described by a binary string of length <italic>M</italic>. Disconnected strings of beads are rejected, and the scattering amplitudes are calculated. Simulated annealing is then used to search for a compact model that minimizes the discrepancy between the experimental and calculated intensities of momentum transfer. The results of 10 independent DAMMIF reconstructions were compared using SUPCOMB13<xref rid="bb0295" ref-type="bibr"><sup>59</sup></xref> to determine the most representative (typical) model. Averaged DAMMIF models were also determined using DAMAVER, and these models were adjusted such that they agree with the experimentally determined excluded volume using DAMFILT.<xref rid="bb0430" ref-type="bibr"><sup>86</sup></xref></p>
        <p>Molecular modeling used, as rigid bodies and where appropriate, the same structures as used for EOM. Rigid-body models were generated using the program CORAL, an advanced version of the rigid-body modeling program BUNCH<xref rid="bb0405 bb0435" ref-type="bibr"><sup>81,87</sup></xref> where linkers/loops between individual subunits are represented as random polypeptide chains. The results of 10 independent CORAL runs were analyzed using the programs SUPCOMB13 and DAMAVER to identify the most representative/typical models.</p>
      </sec>
      <sec id="s0100">
        <title>Combining SAXS and NOEs</title>
        <p>A concatenated FH 10â12 NOE list was created by merging experimentally derived FH 10â11 and FH 11â12 NOE lists. Only NOEs from the FH 10â11 list that involve residues in (and between) CCP 10, the CCP 10â11 linker and the N-terminal half of the threeâdimensional structure of CCP 11 were used; likewise, the only NOEs extracted for use from the FH 11â12 list were those in (and between) the C-terminal half of the threeâdimensional structure of CCP 11, the CCP 11â12 linker and CCP 12. This procedure, similar to that described previously,<xref rid="bb0280" ref-type="bibr"><sup>56</sup></xref> was designed to remove potential duplications and conflict involving the common CCP 11.</p>
        <p>Structure calculations, incorporating the SAXS data for FH 10â12 and the concatenated NOE list, were carried out in Xplor-NIH version 2.30.<xref rid="bb0275" ref-type="bibr"><sup>55</sup></xref> A naive model of FH 10â12, prepared using MODELLER 9v10<xref rid="bb0440" ref-type="bibr"><sup>88</sup></xref> by overlaying closest-to-mean structures of FH 10â11 and FH 11â12 on the common CCP 11, was used as a starting structure. In the first stage of a simulated annealing protocol,<xref rid="bb0275" ref-type="bibr"><sup>55</sup></xref> the temperature was lowered from an initial 2000Â K to 600Â K in 50-K intervals, with 300 steps of molecular dynamics at each temperature increment; within this temperature interval, the energy terms were progressively introduced by multiplicative ramping. In the second stage, the structures were cooled from 600Â K to 100Â K, in increments of 25Â K, with 300 steps of molecular dynamics at each temperature; potential terms were statically set to the top values used in the first stage of cooling. Two calculations were carried out: first, a set of 100 standard protein structures was calculated; second, 100 ensembles of structures (with number of members <italic>N</italic>Â =Â 2 in each ensemble) were calculated. In the ensemble calculation, the energy terms were calculated as an ensemble average, as described before.<xref rid="bb0305" ref-type="bibr"><sup>61</sup></xref> Similar calculations were performed for FH 10â11 and FH 11â12, using the relevant SAXS data and NOE lists and NOE-only derived structures as starting structures.</p>
      </sec>
      <sec id="s0105">
        <title>Relaxation data</title>
        <p>Measurements of backbone <sup>15</sup>N <italic>T</italic><sub>1</sub> and <italic>T</italic><sub>2</sub> and <sup>1</sup>H,<sup>15</sup>N NOEs were conducted using a 600-MHz magnet and 0.45ânM and 0.65âmM (for FH 10â11 and FH 11â12, respectively) samples in 20Â mM potassium phosphate buffer, pHÂ 6.7 (FH 10â11) or pHÂ 6.3 (FH 11â12). Delays used for <italic>T</italic><sub>1</sub> (ms) were (FH 10â11) 51.2, 51.2, 301.2, 501.2, 601.2, 751.2, 851.2 and 901.2 or (FH 11â12) 51.2, 301.2, 501.2, 601.2, 701.2, 801.2 and 901.2. Delays used for <italic>T</italic><sub>2</sub> (ms) (FH 10â11) were 16.96, 16.96, 33.92, 67.84, 101.76, 118.72, 135.68 and 152.64 or (FH 11â12) 16.96, 33.92, 67.84, 84.8, 101.76, 118.82 and 135.68. For heteronuclear NOE measurements, a reference experiment with a 5-s relaxation delay was followed by a second spectrum recorded with <sup>1</sup>H saturation achieved by a train of 120Â° pulses applied for the last 3Â s of the 5-s delay to attain NOE build up. The NMR data were processed using AZARA, and spectra were assigned using Analysis.<xref rid="bb0375" ref-type="bibr"><sup>75</sup></xref> Relaxation rates were obtained by fitting a single-exponential decay to the extracted cross-peak height of each residue using nonlinear fitting. In the case of FH 10â11, the following native residues were excluded from the analyses: Glu566, Arg567, Lys583, His613, Ser652 and Gly676 (signals form the backbone amides were too weak); Asp581, Val589, Val592, Phe595, Cys597, Phe601, Val609, Val627, Thr645, Tyr649 and Ile671 (due to overlap); and Asp675 (amide not found). In the case of FH 11â12, the following native residues were excluded: Ser652, His735 and Gly736 (weak signals); Tyr658, Leu697, Gln703, Tyr709, Ile731 and Cys733 (due to overlap); and Asp675 (amide not found).</p>
      </sec>
      <sec id="s0110">
        <title>Accession numbers</title>
        <p>NMR data and structure coordinates have been deposited at the BMRB (<italic>B</italic>iological <italic>M</italic>agnetic <italic>R</italic>esonance <italic>B</italic>ank) and at the PDB (<italic>P</italic>rotein <italic>D</italic>ata <italic>B</italic>ank). Accession numbers are as follows:<list list-type="simple"><list-item id="u0005"><p>FH 10â11: PDB, <ext-link ext-link-type="uri" xlink:href="pdb:4b2r">4b2r</ext-link>; BMRB, 18604</p></list-item><list-item id="u0010"><p>FH 11â12: PDB, <ext-link ext-link-type="uri" xlink:href="pdb:4b2s">4b2s</ext-link>; BMRB, 18599</p></list-item></list></p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bb0005">
        <label>1</label>
        <element-citation publication-type="journal" id="rf0005">
          <person-group person-group-type="author">
            <name>
              <surname>Walport</surname>
              <given-names>M.J.</given-names>
            </name>
          </person-group>
          <article-title>Complement. First of two parts</article-title>
          <source>N. Engl. J. Med.</source>
          <volume>344</volume>
          <year>2001</year>
          <fpage>1058</fpage>
          <lpage>1066</lpage>
          <pub-id pub-id-type="pmid">11287977</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0010">
        <label>2</label>
        <element-citation publication-type="journal" id="rf0010">
          <person-group person-group-type="author">
            <name>
              <surname>Walport</surname>
              <given-names>M.J.</given-names>
            </name>
          </person-group>
          <article-title>Complement. Second of two parts</article-title>
          <source>N. Engl. J. Med.</source>
          <volume>344</volume>
          <year>2001</year>
          <fpage>1140</fpage>
          <lpage>1144</lpage>
          <pub-id pub-id-type="pmid">11297706</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0015">
        <label>3</label>
        <element-citation publication-type="journal" id="rf0015">
          <person-group person-group-type="author">
            <name>
              <surname>Ricklin</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hajishengallis</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Lambris</surname>
              <given-names>J.D.</given-names>
            </name>
          </person-group>
          <article-title>Complement: a key system for immune surveillance and homeostasis</article-title>
          <source>Nat. Immunol.</source>
          <volume>11</volume>
          <year>2010</year>
          <fpage>785</fpage>
          <lpage>797</lpage>
          <pub-id pub-id-type="pmid">20720586</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0020">
        <label>4</label>
        <element-citation publication-type="journal" id="rf0020">
          <person-group person-group-type="author">
            <name>
              <surname>Pangburn</surname>
              <given-names>M.K.</given-names>
            </name>
            <name>
              <surname>Schreiber</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Muller-Eberhard</surname>
              <given-names>H.J.</given-names>
            </name>
          </person-group>
          <article-title>Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3</article-title>
          <source>J. Exp. Med.</source>
          <volume>154</volume>
          <year>1981</year>
          <fpage>856</fpage>
          <lpage>867</lpage>
          <pub-id pub-id-type="pmid">6912277</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0025">
        <label>5</label>
        <element-citation publication-type="journal" id="rf0025">
          <person-group person-group-type="author">
            <name>
              <surname>Lachmann</surname>
              <given-names>P.J.</given-names>
            </name>
          </person-group>
          <article-title>The amplification loop of the complement pathways</article-title>
          <source>Adv. Immunol.</source>
          <volume>104</volume>
          <year>2009</year>
          <fpage>115</fpage>
          <lpage>149</lpage>
          <pub-id pub-id-type="pmid">20457117</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0030">
        <label>6</label>
        <element-citation publication-type="journal" id="rf0030">
          <person-group person-group-type="author">
            <name>
              <surname>Tack</surname>
              <given-names>B.F.</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Janatova</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Prahl</surname>
              <given-names>J.W.</given-names>
            </name>
          </person-group>
          <article-title>Evidence for presence of an internal thiolester bond in third component of human complement</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <volume>77</volume>
          <year>1980</year>
          <fpage>5764</fpage>
          <lpage>5768</lpage>
          <pub-id pub-id-type="pmid">6934510</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0035">
        <label>7</label>
        <element-citation publication-type="journal" id="rf0035">
          <person-group person-group-type="author">
            <name>
              <surname>Kirkitadze</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Barlow</surname>
              <given-names>P.N.</given-names>
            </name>
          </person-group>
          <article-title>Structure and flexibility of the multiple domain proteins that regulate complement activation</article-title>
          <source>Immunol. Rev.</source>
          <volume>180</volume>
          <year>2001</year>
          <fpage>146</fpage>
          <lpage>161</lpage>
          <pub-id pub-id-type="pmid">11414356</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0040">
        <label>8</label>
        <element-citation publication-type="journal" id="rf0040">
          <person-group person-group-type="author">
            <name>
              <surname>Meri</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Pangburn</surname>
              <given-names>M.K.</given-names>
            </name>
          </person-group>
          <article-title>Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <volume>87</volume>
          <year>1990</year>
          <fpage>3982</fpage>
          <lpage>3986</lpage>
          <pub-id pub-id-type="pmid">1692629</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0045">
        <label>9</label>
        <element-citation publication-type="journal" id="rf0045">
          <person-group person-group-type="author">
            <name>
              <surname>Rosen</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Law</surname>
              <given-names>S.K.</given-names>
            </name>
          </person-group>
          <article-title>The leukocyte cell surface receptor(s) for the iC3b product of complement</article-title>
          <source>Curr. Top. Microbiol. Immunol.</source>
          <volume>153</volume>
          <year>1990</year>
          <fpage>99</fpage>
          <lpage>122</lpage>
          <pub-id pub-id-type="pmid">2137074</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0050">
        <label>10</label>
        <element-citation publication-type="journal" id="rf0050">
          <person-group person-group-type="author">
            <name>
              <surname>Esparza-Gordillo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Soria</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Buil</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Almasy</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Blangero</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Fontcuberta</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Rodriguez de Cordoba</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Genetic and environmental factors influencing the human factor H plasma levels</article-title>
          <source>Immunogenetics</source>
          <volume>56</volume>
          <year>2004</year>
          <fpage>77</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="pmid">15118848</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0055">
        <label>11</label>
        <element-citation publication-type="journal" id="rf0055">
          <person-group person-group-type="author">
            <name>
              <surname>Weiler</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Daha</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Austen</surname>
              <given-names>K.F.</given-names>
            </name>
            <name>
              <surname>Fearon</surname>
              <given-names>D.T.</given-names>
            </name>
          </person-group>
          <article-title>Control of the amplification convertase of complement by the plasma protein Î²1H</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <volume>73</volume>
          <year>1976</year>
          <fpage>3268</fpage>
          <lpage>3272</lpage>
          <pub-id pub-id-type="pmid">1067618</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0060">
        <label>12</label>
        <element-citation publication-type="journal" id="rf0060">
          <person-group person-group-type="author">
            <name>
              <surname>Sim</surname>
              <given-names>R.B.</given-names>
            </name>
            <name>
              <surname>DiScipio</surname>
              <given-names>R.G.</given-names>
            </name>
          </person-group>
          <article-title>Purification and structural studies on the complement-system control protein Î²<sub>1</sub>H (factor H)</article-title>
          <source>Biochem. J.</source>
          <volume>205</volume>
          <year>1982</year>
          <fpage>285</fpage>
          <lpage>293</lpage>
          <pub-id pub-id-type="pmid">6215918</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0065">
        <label>13</label>
        <element-citation publication-type="journal" id="rf0065">
          <person-group person-group-type="author">
            <name>
              <surname>de Cordoba</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>de Jorge</surname>
              <given-names>E.G.</given-names>
            </name>
          </person-group>
          <article-title>Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H</article-title>
          <source>Clin. Exp. Immunol.</source>
          <volume>151</volume>
          <year>2008</year>
          <fpage>1</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">18081690</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0070">
        <label>14</label>
        <element-citation publication-type="journal" id="rf0070">
          <person-group person-group-type="author">
            <name>
              <surname>Hageman</surname>
              <given-names>G.S.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>D.H.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>L.V.</given-names>
            </name>
            <name>
              <surname>Hancox</surname>
              <given-names>L.S.</given-names>
            </name>
            <name>
              <surname>Taiber</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Hardisty</surname>
              <given-names>L.I.</given-names>
            </name>
          </person-group>
          <article-title>A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <volume>102</volume>
          <year>2005</year>
          <fpage>7227</fpage>
          <lpage>7232</lpage>
          <pub-id pub-id-type="pmid">15870199</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0075">
        <label>15</label>
        <element-citation publication-type="journal" id="rf0075">
          <person-group person-group-type="author">
            <name>
              <surname>Pangburn</surname>
              <given-names>M.K.</given-names>
            </name>
          </person-group>
          <article-title>Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement</article-title>
          <source>Immunopharmacology</source>
          <volume>49</volume>
          <year>2000</year>
          <fpage>149</fpage>
          <lpage>157</lpage>
          <pub-id pub-id-type="pmid">10904114</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0080">
        <label>16</label>
        <element-citation publication-type="journal" id="rf0080">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>C.Q.</given-names>
            </name>
            <name>
              <surname>Herbert</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Hocking</surname>
              <given-names>H.G.</given-names>
            </name>
            <name>
              <surname>Uhrin</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Barlow</surname>
              <given-names>P.N.</given-names>
            </name>
          </person-group>
          <article-title>Translational mini-review series on complement factor H: structural and functional correlations for factor H</article-title>
          <source>Clin. Exp. Immunol.</source>
          <volume>151</volume>
          <year>2008</year>
          <fpage>14</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="pmid">18081691</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0085">
        <label>17</label>
        <element-citation publication-type="journal" id="rf0085">
          <person-group person-group-type="author">
            <name>
              <surname>Brook</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Herbert</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Jenkins</surname>
              <given-names>H.T.</given-names>
            </name>
            <name>
              <surname>Soares</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Barlow</surname>
              <given-names>P.N.</given-names>
            </name>
          </person-group>
          <article-title>Opportunities for new therapies based on the natural regulators of complement activation</article-title>
          <source>Ann. N. Y. Acad. Sci.</source>
          <volume>1056</volume>
          <year>2005</year>
          <fpage>176</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="pmid">16387686</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0090">
        <label>18</label>
        <element-citation publication-type="journal" id="rf0090">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Alexander</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Barlow</surname>
              <given-names>P.N.</given-names>
            </name>
            <name>
              <surname>Botto</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cassavant</surname>
              <given-names>T.L.</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>H.T.</given-names>
            </name>
          </person-group>
          <article-title>New approaches to the treatment of dense deposit disease</article-title>
          <source>J. Am. Soc. Nephrol.</source>
          <volume>18</volume>
          <year>2007</year>
          <fpage>2447</fpage>
          <lpage>2456</lpage>
          <pub-id pub-id-type="pmid">17675665</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0095">
        <label>19</label>
        <element-citation publication-type="journal" id="rf0095">
          <person-group person-group-type="author">
            <name>
              <surname>Ricklin</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Lambris</surname>
              <given-names>J.D.</given-names>
            </name>
          </person-group>
          <article-title>Complement-targeted therapeutics</article-title>
          <source>Nat. Biotechnol.</source>
          <volume>25</volume>
          <year>2007</year>
          <fpage>1265</fpage>
          <lpage>1275</lpage>
          <pub-id pub-id-type="pmid">17989689</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0100">
        <label>20</label>
        <element-citation publication-type="journal" id="rf0100">
          <person-group person-group-type="author">
            <name>
              <surname>Reid</surname>
              <given-names>K.B.</given-names>
            </name>
            <name>
              <surname>Day</surname>
              <given-names>A.J.</given-names>
            </name>
          </person-group>
          <article-title>Structureâfunction relationships of the complement components</article-title>
          <source>Immunol. Today</source>
          <volume>10</volume>
          <year>1989</year>
          <fpage>177</fpage>
          <lpage>180</lpage>
          <pub-id pub-id-type="pmid">2751824</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0105">
        <label>21</label>
        <element-citation publication-type="journal" id="rf0105">
          <person-group person-group-type="author">
            <name>
              <surname>Ripoche</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Day</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Willis</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Belt</surname>
              <given-names>K.T.</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Sim</surname>
              <given-names>R.B.</given-names>
            </name>
          </person-group>
          <article-title>Partial characterization of human complement factor H by protein and cDNA sequencing: homology with other complement and non-complement proteins</article-title>
          <source>Biosci. Rep.</source>
          <volume>6</volume>
          <year>1986</year>
          <fpage>65</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="pmid">2938641</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0110">
        <label>22</label>
        <element-citation publication-type="journal" id="rf0110">
          <person-group person-group-type="author">
            <name>
              <surname>Ripoche</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Day</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Sim</surname>
              <given-names>R.B.</given-names>
            </name>
          </person-group>
          <article-title>The complete amino acid sequence of human complement factor H</article-title>
          <source>Biochem. J.</source>
          <volume>249</volume>
          <year>1988</year>
          <fpage>593</fpage>
          <lpage>602</lpage>
          <pub-id pub-id-type="pmid">2963625</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0115">
        <label>23</label>
        <element-citation publication-type="journal" id="rf0115">
          <person-group person-group-type="author">
            <name>
              <surname>Perkins</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Nealis</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Sim</surname>
              <given-names>R.B.</given-names>
            </name>
          </person-group>
          <article-title>Oligomeric domain structure of human complement factor H by X-ray and neutron solution scattering</article-title>
          <source>Biochemistry</source>
          <volume>30</volume>
          <year>1991</year>
          <fpage>2847</fpage>
          <lpage>2857</lpage>
          <pub-id pub-id-type="pmid">1826087</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0120">
        <label>24</label>
        <element-citation publication-type="journal" id="rf0120">
          <person-group person-group-type="author">
            <name>
              <surname>DiScipio</surname>
              <given-names>R.G.</given-names>
            </name>
          </person-group>
          <article-title>Ultrastructures and interactions of complement factors H and I</article-title>
          <source>J. Immunol.</source>
          <volume>149</volume>
          <year>1992</year>
          <fpage>2592</fpage>
          <lpage>2599</lpage>
          <pub-id pub-id-type="pmid">1401896</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0125">
        <label>25</label>
        <element-citation publication-type="journal" id="rf0125">
          <person-group person-group-type="author">
            <name>
              <surname>Aslam</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Perkins</surname>
              <given-names>S.J.</given-names>
            </name>
          </person-group>
          <article-title>Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling</article-title>
          <source>J. Mol. Biol.</source>
          <volume>309</volume>
          <year>2001</year>
          <fpage>1117</fpage>
          <lpage>1138</lpage>
          <pub-id pub-id-type="pmid">11399083</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0130">
        <label>26</label>
        <element-citation publication-type="journal" id="rf0130">
          <person-group person-group-type="author">
            <name>
              <surname>Okemefuna</surname>
              <given-names>A.I.</given-names>
            </name>
            <name>
              <surname>Gilbert</surname>
              <given-names>H.E.</given-names>
            </name>
            <name>
              <surname>Griggs</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Ormsby</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Gordon</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Perkins</surname>
              <given-names>S.J.</given-names>
            </name>
          </person-group>
          <article-title>The regulatory SCR-1/5 and cell surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative properties</article-title>
          <source>J. Mol. Biol.</source>
          <volume>375</volume>
          <year>2008</year>
          <fpage>80</fpage>
          <lpage>101</lpage>
          <pub-id pub-id-type="pmid">18005991</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0135">
        <label>27</label>
        <element-citation publication-type="journal" id="rf0135">
          <person-group person-group-type="author">
            <name>
              <surname>Barlow</surname>
              <given-names>P.N.</given-names>
            </name>
            <name>
              <surname>Baron</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Norman</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Day</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Willis</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Sim</surname>
              <given-names>R.B.</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>I.D.</given-names>
            </name>
          </person-group>
          <article-title>Secondary structure of a complement control protein module by two-dimensional <sup>1</sup>H NMR</article-title>
          <source>Biochemistry</source>
          <volume>30</volume>
          <year>1991</year>
          <fpage>997</fpage>
          <lpage>1004</lpage>
          <pub-id pub-id-type="pmid">1824927</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0140">
        <label>28</label>
        <element-citation publication-type="journal" id="rf0140">
          <person-group person-group-type="author">
            <name>
              <surname>Norman</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Barlow</surname>
              <given-names>P.N.</given-names>
            </name>
            <name>
              <surname>Baron</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Day</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Sim</surname>
              <given-names>R.B.</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>I.D.</given-names>
            </name>
          </person-group>
          <article-title>Three-dimensional structure of a complement control protein module in solution</article-title>
          <source>J. Mol. Biol.</source>
          <volume>219</volume>
          <year>1991</year>
          <fpage>717</fpage>
          <lpage>725</lpage>
          <pub-id pub-id-type="pmid">1829116</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0145">
        <label>29</label>
        <element-citation publication-type="journal" id="rf0145">
          <person-group person-group-type="author">
            <name>
              <surname>Barlow</surname>
              <given-names>P.N.</given-names>
            </name>
            <name>
              <surname>Steinkasserer</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Norman</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Kieffer</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Wiles</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Sim</surname>
              <given-names>R.B.</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>I.D.</given-names>
            </name>
          </person-group>
          <article-title>Solution structure of a pair of complement modules by nuclear magnetic resonance</article-title>
          <source>J. Mol. Biol.</source>
          <volume>232</volume>
          <year>1993</year>
          <fpage>268</fpage>
          <lpage>284</lpage>
          <pub-id pub-id-type="pmid">8331663</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0150">
        <label>30</label>
        <element-citation publication-type="journal" id="rf0150">
          <person-group person-group-type="author">
            <name>
              <surname>Herbert</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Uhrin</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Lyon</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Pangburn</surname>
              <given-names>M.K.</given-names>
            </name>
            <name>
              <surname>Barlow</surname>
              <given-names>P.N.</given-names>
            </name>
          </person-group>
          <article-title>Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in 3D structure</article-title>
          <source>J. Biol. Chem.</source>
          <volume>281</volume>
          <year>2006</year>
          <fpage>16512</fpage>
          <lpage>16520</lpage>
          <pub-id pub-id-type="pmid">16533809</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0155">
        <label>31</label>
        <element-citation publication-type="journal" id="rf0155">
          <person-group person-group-type="author">
            <name>
              <surname>Jokiranta</surname>
              <given-names>T.S.</given-names>
            </name>
            <name>
              <surname>Jaakola</surname>
              <given-names>V.P.</given-names>
            </name>
            <name>
              <surname>Lehtinen</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Parepalo</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Meri</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Goldman</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome</article-title>
          <source>EMBO J.</source>
          <volume>25</volume>
          <year>2006</year>
          <fpage>1784</fpage>
          <lpage>1794</lpage>
          <pub-id pub-id-type="pmid">16601698</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0160">
        <label>32</label>
        <element-citation publication-type="journal" id="rf0160">
          <person-group person-group-type="author">
            <name>
              <surname>Prosser</surname>
              <given-names>B.E.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Roversi</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Herbert</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Blaum</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Tyrrell</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Structural basis for complement factor H linked age-related macular degeneration</article-title>
          <source>J. Exp. Med.</source>
          <volume>204</volume>
          <year>2007</year>
          <fpage>2277</fpage>
          <lpage>2283</lpage>
          <pub-id pub-id-type="pmid">17893204</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0165">
        <label>33</label>
        <element-citation publication-type="journal" id="rf0165">
          <person-group person-group-type="author">
            <name>
              <surname>Hocking</surname>
              <given-names>H.G.</given-names>
            </name>
            <name>
              <surname>Herbert</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Kavanagh</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Soares</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>V.P.</given-names>
            </name>
            <name>
              <surname>Pangburn</surname>
              <given-names>M.K.</given-names>
            </name>
          </person-group>
          <article-title>Structure of the N-terminal region of complement factor H and conformational implications of disease-linked sequence variations</article-title>
          <source>J. Biol. Chem.</source>
          <volume>283</volume>
          <year>2008</year>
          <fpage>9475</fpage>
          <lpage>9487</lpage>
          <pub-id pub-id-type="pmid">18252712</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0170">
        <label>34</label>
        <element-citation publication-type="journal" id="rf0170">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.Q.</given-names>
            </name>
            <name>
              <surname>Ricklin</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Janssen</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Lambris</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Gros</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Structure of complement fragment C3bâfactor H and implications for host protection by complement regulators</article-title>
          <source>Nat. Immunol.</source>
          <volume>10</volume>
          <year>2009</year>
          <fpage>728</fpage>
          <lpage>733</lpage>
          <pub-id pub-id-type="pmid">19503104</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0175">
        <label>35</label>
        <element-citation publication-type="journal" id="rf0175">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>C.Q.</given-names>
            </name>
            <name>
              <surname>Herbert</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Mertens</surname>
              <given-names>H.D.</given-names>
            </name>
            <name>
              <surname>Guariento</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Soares</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Uhrin</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>The central portion of factor H (modules 10â15) is compact and contains a structurally deviant CCP module</article-title>
          <source>J. Mol. Biol.</source>
          <volume>395</volume>
          <year>2010</year>
          <fpage>105</fpage>
          <lpage>122</lpage>
          <pub-id pub-id-type="pmid">19835885</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0180">
        <label>36</label>
        <element-citation publication-type="journal" id="rf0180">
          <person-group person-group-type="author">
            <name>
              <surname>Morgan</surname>
              <given-names>H.P.</given-names>
            </name>
            <name>
              <surname>Mertens</surname>
              <given-names>H.D.</given-names>
            </name>
            <name>
              <surname>Guariento</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>C.Q.</given-names>
            </name>
            <name>
              <surname>Soares</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Svergun</surname>
              <given-names>D.I.</given-names>
            </name>
          </person-group>
          <article-title>Structural analysis of the C-terminal region (modules 18â20) of complement regulator factor H (FH)</article-title>
          <source>PLoS One</source>
          <volume>7</volume>
          <year>2012</year>
          <fpage>e32187</fpage>
          <pub-id pub-id-type="pmid">22389686</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0185">
        <label>37</label>
        <element-citation publication-type="journal" id="rf0185">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>C.Q.</given-names>
            </name>
            <name>
              <surname>Herbert</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Kavanagh</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Gandy</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Fenton</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Blaum</surname>
              <given-names>B.S.</given-names>
            </name>
          </person-group>
          <article-title>A new map of glycosaminoglycan and C3b binding sites on factor H</article-title>
          <source>J. Immunol.</source>
          <volume>181</volume>
          <year>2008</year>
          <fpage>2610</fpage>
          <lpage>2619</lpage>
          <pub-id pub-id-type="pmid">18684951</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0190">
        <label>38</label>
        <element-citation publication-type="journal" id="rf0190">
          <person-group person-group-type="author">
            <name>
              <surname>Pechtl</surname>
              <given-names>I.C.</given-names>
            </name>
            <name>
              <surname>Neely</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Dryden</surname>
              <given-names>D.T.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Barlow</surname>
              <given-names>P.N.</given-names>
            </name>
          </person-group>
          <article-title>Use of time-resolved FRET to validate crystal structure of complement regulatory complex between C3b and factor H (N terminus)</article-title>
          <source>Protein Sci.</source>
          <volume>20</volume>
          <year>2011</year>
          <fpage>2102</fpage>
          <lpage>2112</lpage>
          <pub-id pub-id-type="pmid">21936007</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0195">
        <label>39</label>
        <element-citation publication-type="journal" id="rf0195">
          <person-group person-group-type="author">
            <name>
              <surname>Alsenz</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lambris</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>T.F.</given-names>
            </name>
            <name>
              <surname>Dierich</surname>
              <given-names>M.P.</given-names>
            </name>
          </person-group>
          <article-title>Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38Â kDa tryptic fragment of factor H</article-title>
          <source>Biochem. J.</source>
          <volume>224</volume>
          <year>1984</year>
          <fpage>389</fpage>
          <lpage>398</lpage>
          <pub-id pub-id-type="pmid">6240261</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0200">
        <label>40</label>
        <element-citation publication-type="journal" id="rf0200">
          <person-group person-group-type="author">
            <name>
              <surname>Gordon</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Kaufman</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Blackmore</surname>
              <given-names>T.K.</given-names>
            </name>
            <name>
              <surname>Kwong</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lublin</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>Identification of complement regulatory domains in human factor H</article-title>
          <source>J. Immunol.</source>
          <volume>155</volume>
          <year>1995</year>
          <fpage>348</fpage>
          <lpage>356</lpage>
          <pub-id pub-id-type="pmid">7541419</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0205">
        <label>41</label>
        <element-citation publication-type="journal" id="rf0205">
          <person-group person-group-type="author">
            <name>
              <surname>Sharma</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Pangburn</surname>
              <given-names>M.K.</given-names>
            </name>
          </person-group>
          <article-title>Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <volume>93</volume>
          <year>1996</year>
          <fpage>10996</fpage>
          <lpage>11001</lpage>
          <pub-id pub-id-type="pmid">8855297</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0210">
        <label>42</label>
        <element-citation publication-type="journal" id="rf0210">
          <person-group person-group-type="author">
            <name>
              <surname>Kuhn</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zipfel</surname>
              <given-names>P.F.</given-names>
            </name>
          </person-group>
          <article-title>Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H</article-title>
          <source>Eur. J. Immunol.</source>
          <volume>26</volume>
          <year>1996</year>
          <fpage>2383</fpage>
          <lpage>2387</lpage>
          <pub-id pub-id-type="pmid">8898949</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0215">
        <label>43</label>
        <element-citation publication-type="journal" id="rf0215">
          <person-group person-group-type="author">
            <name>
              <surname>Pangburn</surname>
              <given-names>M.K.</given-names>
            </name>
            <name>
              <surname>Atkinson</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Meri</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Localization of the heparin-binding site on complement factor H</article-title>
          <source>J. Biol. Chem.</source>
          <volume>266</volume>
          <year>1991</year>
          <fpage>16847</fpage>
          <lpage>16853</lpage>
          <pub-id pub-id-type="pmid">1832158</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0220">
        <label>44</label>
        <element-citation publication-type="journal" id="rf0220">
          <person-group person-group-type="author">
            <name>
              <surname>Blackmore</surname>
              <given-names>T.K.</given-names>
            </name>
            <name>
              <surname>Hellwage</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sadlon</surname>
              <given-names>T.A.</given-names>
            </name>
            <name>
              <surname>Higgs</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Zipfel</surname>
              <given-names>P.F.</given-names>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Gordon</surname>
              <given-names>D.L.</given-names>
            </name>
          </person-group>
          <article-title>Identification of the second heparin-binding domain in human complement factor H</article-title>
          <source>J. Immunol.</source>
          <volume>160</volume>
          <year>1998</year>
          <fpage>3342</fpage>
          <lpage>3348</lpage>
          <pub-id pub-id-type="pmid">9531293</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0225">
        <label>45</label>
        <element-citation publication-type="journal" id="rf0225">
          <person-group person-group-type="author">
            <name>
              <surname>Ferreira</surname>
              <given-names>V.P.</given-names>
            </name>
            <name>
              <surname>Herbert</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Hocking</surname>
              <given-names>H.G.</given-names>
            </name>
            <name>
              <surname>Barlow</surname>
              <given-names>P.N.</given-names>
            </name>
            <name>
              <surname>Pangburn</surname>
              <given-names>M.K.</given-names>
            </name>
          </person-group>
          <article-title>Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces</article-title>
          <source>J. Immunol.</source>
          <volume>177</volume>
          <year>2006</year>
          <fpage>6308</fpage>
          <lpage>6316</lpage>
          <pub-id pub-id-type="pmid">17056561</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0230">
        <label>46</label>
        <element-citation publication-type="journal" id="rf0230">
          <person-group person-group-type="author">
            <name>
              <surname>Ferreira</surname>
              <given-names>V.P.</given-names>
            </name>
            <name>
              <surname>Herbert</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Cortes</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>McKee</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Blaum</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Esswein</surname>
              <given-names>S.T.</given-names>
            </name>
          </person-group>
          <article-title>The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome</article-title>
          <source>J. Immunol.</source>
          <volume>182</volume>
          <year>2009</year>
          <fpage>7009</fpage>
          <lpage>7018</lpage>
          <pub-id pub-id-type="pmid">19454698</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0235">
        <label>47</label>
        <element-citation publication-type="journal" id="rf0235">
          <person-group person-group-type="author">
            <name>
              <surname>Morgan</surname>
              <given-names>H.P.</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>C.Q.</given-names>
            </name>
            <name>
              <surname>Guariento</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Blaum</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Gillespie</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Herbert</surname>
              <given-names>A.P.</given-names>
            </name>
          </person-group>
          <article-title>Structural basis for engagement by complement factor H of C3b on a self surface</article-title>
          <source>Nat. Struct. Mol. Biol.</source>
          <volume>18</volume>
          <year>2011</year>
          <fpage>463</fpage>
          <lpage>470</lpage>
          <pub-id pub-id-type="pmid">21317894</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0240">
        <label>48</label>
        <element-citation publication-type="journal" id="rf0240">
          <person-group person-group-type="author">
            <name>
              <surname>Fenaille</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Le Mignon</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Groseil</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ramon</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Riande</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Siret</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Bihoreau</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Site-specific <italic>N</italic>-glycan characterization of human complement factor H</article-title>
          <source>Glycobiology</source>
          <volume>17</volume>
          <year>2007</year>
          <fpage>932</fpage>
          <lpage>944</lpage>
          <pub-id pub-id-type="pmid">17591618</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0245">
        <label>49</label>
        <element-citation publication-type="journal" id="rf0245">
          <person-group person-group-type="author">
            <name>
              <surname>Guntert</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Automated NMR structure calculation with CYANA</article-title>
          <source>Methods Mol. Biol.</source>
          <volume>278</volume>
          <year>2004</year>
          <fpage>353</fpage>
          <lpage>378</lpage>
          <pub-id pub-id-type="pmid">15318003</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0250">
        <label>50</label>
        <element-citation publication-type="journal" id="rf0250">
          <person-group person-group-type="author">
            <name>
              <surname>Brunger</surname>
              <given-names>A.T.</given-names>
            </name>
          </person-group>
          <article-title>Version 1.2 of the crystallography and NMR system</article-title>
          <source>Nat. Protoc.</source>
          <volume>2</volume>
          <year>2007</year>
          <fpage>2728</fpage>
          <lpage>2733</lpage>
          <pub-id pub-id-type="pmid">18007608</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0255">
        <label>51</label>
        <element-citation publication-type="journal" id="rf0255">
          <person-group person-group-type="author">
            <name>
              <surname>Heinig</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Frishman</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>STRIDE: a web server for secondary structure assignment from known atomic coordinates of proteins</article-title>
          <source>Nucleic Acids Res.</source>
          <volume>32</volume>
          <year>2004</year>
          <fpage>W500</fpage>
          <lpage>W502</lpage>
          <pub-id pub-id-type="pmid">15215436</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0260">
        <label>52</label>
        <element-citation publication-type="journal" id="rf0260">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>B.O.</given-names>
            </name>
            <name>
              <surname>Mallin</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Krych-Goldberg</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Hauhart</surname>
              <given-names>R.E.</given-names>
            </name>
            <name>
              <surname>Bromek</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Structure of the C3b binding site of CR1 (CD35), the immune adherence receptor</article-title>
          <source>Cell</source>
          <volume>108</volume>
          <year>2002</year>
          <fpage>769</fpage>
          <lpage>780</lpage>
          <pub-id pub-id-type="pmid">11955431</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0265">
        <label>53</label>
        <element-citation publication-type="journal" id="rf0265">
          <person-group person-group-type="author">
            <name>
              <surname>Persson</surname>
              <given-names>B.D.</given-names>
            </name>
            <name>
              <surname>Schmitz</surname>
              <given-names>N.B.</given-names>
            </name>
            <name>
              <surname>Santiago</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Zocher</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Larvie</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Scheu</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens</article-title>
          <source>PLoS Pathog.</source>
          <volume>6</volume>
          <year>2010</year>
          <fpage>e1001122</fpage>
          <pub-id pub-id-type="pmid">20941397</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0270">
        <label>54</label>
        <element-citation publication-type="journal" id="rf0270">
          <person-group person-group-type="author">
            <name>
              <surname>Szakonyi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Guthridge</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Holers</surname>
              <given-names>V.M.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X.S.</given-names>
            </name>
          </person-group>
          <article-title>Structure of complement receptor 2 in complex with its C3d ligand</article-title>
          <source>Science</source>
          <volume>292</volume>
          <year>2001</year>
          <fpage>1725</fpage>
          <lpage>1728</lpage>
          <pub-id pub-id-type="pmid">11387479</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0275">
        <label>55</label>
        <element-citation publication-type="journal" id="rf0275">
          <person-group person-group-type="author">
            <name>
              <surname>Schwieters</surname>
              <given-names>C.D.</given-names>
            </name>
            <name>
              <surname>Kuszewski</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Clore</surname>
              <given-names>G.M.</given-names>
            </name>
          </person-group>
          <article-title>Using Xplor-NIH for NMR molecular structure determination</article-title>
          <source>Prog. Nucl. Magn. Reson. Spectrosc.</source>
          <volume>48</volume>
          <year>2006</year>
          <fpage>47</fpage>
          <lpage>62</lpage>
        </element-citation>
      </ref>
      <ref id="bb0280">
        <label>56</label>
        <element-citation publication-type="journal" id="rf0280">
          <person-group person-group-type="author">
            <name>
              <surname>Maciejewski</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tjandra</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Barlow</surname>
              <given-names>P.N.</given-names>
            </name>
          </person-group>
          <article-title>Estimation of interdomain flexibility of N-terminus of factor H using residual dipolar couplings</article-title>
          <source>Biochemistry</source>
          <volume>50</volume>
          <year>2011</year>
          <fpage>8138</fpage>
          <lpage>8149</lpage>
          <pub-id pub-id-type="pmid">21793561</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0285">
        <label>57</label>
        <element-citation publication-type="journal" id="rf0285">
          <person-group person-group-type="author">
            <name>
              <surname>Svergun</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Barberato</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>M.H.J.</given-names>
            </name>
          </person-group>
          <article-title>CRYSOLâa program to evaluate x-ray solution scattering of biological macromolecules from atomic coordinates</article-title>
          <source>J. Appl. Crystallogr.</source>
          <volume>28</volume>
          <year>1995</year>
          <fpage>768</fpage>
          <lpage>773</lpage>
        </element-citation>
      </ref>
      <ref id="bb0290">
        <label>58</label>
        <element-citation publication-type="journal" id="rf0290">
          <person-group person-group-type="author">
            <name>
              <surname>Franke</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Svergun</surname>
              <given-names>D.I.</given-names>
            </name>
          </person-group>
          <article-title>DAMMIF, a program for rapid <italic>ab-initio</italic> shape determination in small-angle scattering</article-title>
          <source>J. Appl. Crystallogr.</source>
          <volume>42</volume>
          <year>2009</year>
          <fpage>342</fpage>
          <lpage>346</lpage>
        </element-citation>
      </ref>
      <ref id="bb0295">
        <label>59</label>
        <element-citation publication-type="journal" id="rf0295">
          <person-group person-group-type="author">
            <name>
              <surname>Kozin</surname>
              <given-names>M.B.</given-names>
            </name>
            <name>
              <surname>Svergun</surname>
              <given-names>D.I.</given-names>
            </name>
          </person-group>
          <article-title>Automated matching of high- and low-resolution structural models</article-title>
          <source>J. Appl. Crystallogr.</source>
          <volume>34</volume>
          <year>2001</year>
          <fpage>33</fpage>
          <lpage>41</lpage>
        </element-citation>
      </ref>
      <ref id="bb0300">
        <label>60</label>
        <element-citation publication-type="journal" id="rf0300">
          <person-group person-group-type="author">
            <name>
              <surname>Schwieters</surname>
              <given-names>C.D.</given-names>
            </name>
            <name>
              <surname>Suh</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>Grishaev</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ghirlando</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Takayama</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Clore</surname>
              <given-names>G.M.</given-names>
            </name>
          </person-group>
          <article-title>Solution structure of the 128Â kDa enzyme I dimer from <italic>Escherichia coli</italic> and its 146Â kDa complex with HPr using residual dipolar couplings and small- and wide-angle X-ray scattering</article-title>
          <source>J. Am. Chem. Soc.</source>
          <volume>132</volume>
          <year>2010</year>
          <fpage>13026</fpage>
          <lpage>13045</lpage>
          <pub-id pub-id-type="pmid">20731394</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0305">
        <label>61</label>
        <element-citation publication-type="journal" id="rf0305">
          <person-group person-group-type="author">
            <name>
              <surname>Clore</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Schwieters</surname>
              <given-names>C.D.</given-names>
            </name>
          </person-group>
          <article-title>How much backbone motion in ubiquitin is required to account for dipolar coupling data measured in multiple alignment media as assessed by independent cross-validation?</article-title>
          <source>J. Am. Chem. Soc.</source>
          <volume>126</volume>
          <year>2004</year>
          <fpage>2923</fpage>
          <lpage>2938</lpage>
          <pub-id pub-id-type="pmid">14995210</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0310">
        <label>62</label>
        <element-citation publication-type="journal" id="rf0310">
          <person-group person-group-type="author">
            <name>
              <surname>Bernado</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Mylonas</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Petoukhov</surname>
              <given-names>M.V.</given-names>
            </name>
            <name>
              <surname>Blackledge</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Svergun</surname>
              <given-names>D.I.</given-names>
            </name>
          </person-group>
          <article-title>Structural characterization of flexible proteins using small-angle X-ray scattering</article-title>
          <source>J. Am. Chem. Soc.</source>
          <volume>129</volume>
          <year>2007</year>
          <fpage>5656</fpage>
          <lpage>5664</lpage>
          <pub-id pub-id-type="pmid">17411046</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0315">
        <label>63</label>
        <element-citation publication-type="journal" id="rf0315">
          <person-group person-group-type="author">
            <name>
              <surname>Soares</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Gerloff</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Syme</surname>
              <given-names>N.R.</given-names>
            </name>
            <name>
              <surname>Coulson</surname>
              <given-names>A.F.</given-names>
            </name>
            <name>
              <surname>Parkinson</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Barlow</surname>
              <given-names>P.N.</given-names>
            </name>
          </person-group>
          <article-title>Large-scale modelling as a route to multiple surface comparisons of the CCP module family</article-title>
          <source>Protein Eng., Des. Sel.</source>
          <volume>18</volume>
          <year>2005</year>
          <fpage>379</fpage>
          <lpage>388</lpage>
          <pub-id pub-id-type="pmid">15976010</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0320">
        <label>64</label>
        <element-citation publication-type="journal" id="rf0320">
          <person-group person-group-type="author">
            <name>
              <surname>Kajander</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Lehtinen</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Hyvarinen</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Bhattacharjee</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Isenman</surname>
              <given-names>D.E.</given-names>
            </name>
          </person-group>
          <article-title>Dual interaction of factor H with C3d and glycosaminoglycans in hostânonhost discrimination by complement</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <volume>108</volume>
          <year>2011</year>
          <fpage>2897</fpage>
          <lpage>2902</lpage>
          <pub-id pub-id-type="pmid">21285368</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0325">
        <label>65</label>
        <element-citation publication-type="journal" id="rf0325">
          <person-group person-group-type="author">
            <name>
              <surname>Okemefuna</surname>
              <given-names>A.I.</given-names>
            </name>
            <name>
              <surname>Nan</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Gor</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Perkins</surname>
              <given-names>S.J.</given-names>
            </name>
          </person-group>
          <article-title>Electrostatic interactions contribute to the folded-back conformation of wild type human factor H</article-title>
          <source>J. Mol. Biol.</source>
          <volume>391</volume>
          <year>2009</year>
          <fpage>98</fpage>
          <lpage>118</lpage>
          <pub-id pub-id-type="pmid">19505476</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0330">
        <label>66</label>
        <element-citation publication-type="journal" id="rf0330">
          <person-group person-group-type="author">
            <name>
              <surname>Fenaille</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Le Mignon</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Groseil</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Siret</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Bihoreau</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Combined use of 2,4,6-trihydroxyacetophenone as matrix and enzymatic deglycosylation in organic-aqueous solvent systems for the simultaneous characterization of complex glycoproteins and <italic>N</italic>-glycans by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry</article-title>
          <source>Rapid Commun. Mass Spectrom.</source>
          <volume>21</volume>
          <year>2007</year>
          <fpage>812</fpage>
          <lpage>816</lpage>
          <pub-id pub-id-type="pmid">17279484</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0335">
        <label>67</label>
        <element-citation publication-type="journal" id="rf0335">
          <person-group person-group-type="author">
            <name>
              <surname>Kirkitadze</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Dryden</surname>
              <given-names>D.T.</given-names>
            </name>
            <name>
              <surname>Kelly</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Price</surname>
              <given-names>N.C.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Krych</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Co-operativity between modules within a C3b-binding site of complement receptor type 1</article-title>
          <source>FEBS Lett.</source>
          <volume>459</volume>
          <year>1999</year>
          <fpage>133</fpage>
          <lpage>138</lpage>
          <pub-id pub-id-type="pmid">10508932</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0340">
        <label>68</label>
        <element-citation publication-type="journal" id="rf0340">
          <person-group person-group-type="author">
            <name>
              <surname>Kirkitadze</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Krych</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Uhrin</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Dryden</surname>
              <given-names>D.T.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>B.O.</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Independently melting modules and highly structured intermodular junctions within complement receptor type 1</article-title>
          <source>Biochemistry</source>
          <volume>38</volume>
          <year>1999</year>
          <fpage>7019</fpage>
          <lpage>7031</lpage>
          <pub-id pub-id-type="pmid">10353813</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0345">
        <label>69</label>
        <element-citation publication-type="journal" id="rf0345">
          <person-group person-group-type="author">
            <name>
              <surname>Rickert</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Boulanger</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Goriatcheva</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>K.C.</given-names>
            </name>
          </person-group>
          <article-title>The structure of interleukin-2 complexed with its alpha receptor</article-title>
          <source>Science</source>
          <volume>308</volume>
          <year>2005</year>
          <fpage>1477</fpage>
          <lpage>1480</lpage>
          <pub-id pub-id-type="pmid">15933202</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0350">
        <label>70</label>
        <element-citation publication-type="journal" id="rf0350">
          <person-group person-group-type="author">
            <name>
              <surname>Andersen</surname>
              <given-names>C.B.</given-names>
            </name>
            <name>
              <surname>Torvund-Jensen</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nielsen</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>de Oliveira</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Hersleth</surname>
              <given-names>H.P.</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>N.H.</given-names>
            </name>
          </person-group>
          <article-title>Structure of the haptoglobinâhaemoglobin complex</article-title>
          <source>Nature</source>
          <volume>489</volume>
          <year>2012</year>
          <fpage>456</fpage>
          <lpage>459</lpage>
          <pub-id pub-id-type="pmid">22922649</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0355">
        <label>71</label>
        <element-citation publication-type="journal" id="rf0355">
          <person-group person-group-type="author">
            <name>
              <surname>Blein</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ginham</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Uhrin</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>B.O.</given-names>
            </name>
            <name>
              <surname>Soares</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Veltel</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Structural analysis of the complement control protein (CCP) modules of GABA(B) receptor 1a: only one of the two CCP modules is compactly folded</article-title>
          <source>J. Biol. Chem.</source>
          <volume>279</volume>
          <year>2004</year>
          <fpage>48292</fpage>
          <lpage>48306</lpage>
          <pub-id pub-id-type="pmid">15304491</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0360">
        <label>72</label>
        <element-citation publication-type="journal" id="rf0360">
          <person-group person-group-type="author">
            <name>
              <surname>Ishida</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Prediction of disordered regions in proteins based on the meta approach</article-title>
          <source>Bioinformatics</source>
          <volume>24</volume>
          <year>2008</year>
          <fpage>1344</fpage>
          <lpage>1348</lpage>
          <pub-id pub-id-type="pmid">18426805</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0365">
        <label>73</label>
        <element-citation publication-type="journal" id="rf0365">
          <person-group person-group-type="author">
            <name>
              <surname>Oppermann</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Manuelian</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Jozsi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Jokiranta</surname>
              <given-names>T.S.</given-names>
            </name>
            <name>
              <surname>Heinen</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein</article-title>
          <source>Clin. Exp. Immunol.</source>
          <volume>144</volume>
          <year>2006</year>
          <fpage>342</fpage>
          <lpage>352</lpage>
          <pub-id pub-id-type="pmid">16634809</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0370">
        <label>74</label>
        <element-citation publication-type="journal" id="rf0370">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>C.Q.</given-names>
            </name>
            <name>
              <surname>Slingsby</surname>
              <given-names>F.C.</given-names>
            </name>
            <name>
              <surname>Richards</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Barlow</surname>
              <given-names>P.N.</given-names>
            </name>
          </person-group>
          <article-title>Production of biologically active complement factor H in therapeutically useful quantities</article-title>
          <source>Protein Expression Purif.</source>
          <volume>76</volume>
          <year>2011</year>
          <fpage>254</fpage>
          <lpage>263</lpage>
        </element-citation>
      </ref>
      <ref id="bb0375">
        <label>75</label>
        <element-citation publication-type="journal" id="rf0375">
          <person-group person-group-type="author">
            <name>
              <surname>Vranken</surname>
              <given-names>W.F.</given-names>
            </name>
            <name>
              <surname>Boucher</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Fogh</surname>
              <given-names>R.H.</given-names>
            </name>
            <name>
              <surname>Pajon</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Llinas</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>The CCPN data model for NMR spectroscopy: development of a software pipeline</article-title>
          <source>Proteins</source>
          <volume>59</volume>
          <year>2005</year>
          <fpage>687</fpage>
          <lpage>696</lpage>
          <pub-id pub-id-type="pmid">15815974</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0380">
        <label>76</label>
        <element-citation publication-type="journal" id="rf0380">
          <person-group person-group-type="author">
            <name>
              <surname>Schubert</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Labudde</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Oschkinat</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Schmieder</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>A software tool for the prediction of Xaa-Pro peptide bond conformations in proteins based on <sup>13</sup>C chemical shift statistics</article-title>
          <source>J. Biomol. NMR</source>
          <volume>24</volume>
          <year>2002</year>
          <fpage>149</fpage>
          <lpage>154</lpage>
          <pub-id pub-id-type="pmid">12495031</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0385">
        <label>77</label>
        <element-citation publication-type="journal" id="rf0385">
          <person-group person-group-type="author">
            <name>
              <surname>Laskowski</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Macarthur</surname>
              <given-names>M.W.</given-names>
            </name>
            <name>
              <surname>Moss</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Thornton</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>PROCHECK: a program to check the stereochemical quality of protein structures</article-title>
          <source>J. Appl. Crystallogr.</source>
          <volume>26</volume>
          <year>1993</year>
          <fpage>283</fpage>
          <lpage>291</lpage>
        </element-citation>
      </ref>
      <ref id="bb0390">
        <label>78</label>
        <element-citation publication-type="journal" id="rf0390">
          <person-group person-group-type="author">
            <name>
              <surname>Willard</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Ranjan</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Monzavi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Boyko</surname>
              <given-names>R.F.</given-names>
            </name>
            <name>
              <surname>Sykes</surname>
              <given-names>B.D.</given-names>
            </name>
            <name>
              <surname>Wishart</surname>
              <given-names>D.S.</given-names>
            </name>
          </person-group>
          <article-title>VADAR: a web server for quantitative evaluation of protein structure quality</article-title>
          <source>Nucleic Acids Res.</source>
          <volume>31</volume>
          <year>2003</year>
          <fpage>3316</fpage>
          <lpage>3319</lpage>
          <pub-id pub-id-type="pmid">12824316</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0395">
        <label>79</label>
        <element-citation publication-type="book" id="rf0395">
          <person-group person-group-type="author">
            <name>
              <surname>Soares</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Barlow</surname>
              <given-names>P.N.</given-names>
            </name>
          </person-group>
          <chapter-title>Complement control protein modules in the regulators of complement activation</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Morikis</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Lambris</surname>
              <given-names>J.D.</given-names>
            </name>
          </person-group>
          <source>Structural Biology of the Complement System</source>
          <year>2005</year>
          <publisher-name>CRC Press, Taylor &amp; Francis Group</publisher-name>
          <publisher-loc>Boca Raton, FL</publisher-loc>
          <fpage>19</fpage>
          <lpage>62</lpage>
        </element-citation>
      </ref>
      <ref id="bb0400">
        <label>80</label>
        <element-citation publication-type="journal" id="rf0400">
          <person-group person-group-type="author">
            <name>
              <surname>Shindyalov</surname>
              <given-names>I.N.</given-names>
            </name>
            <name>
              <surname>Bourne</surname>
              <given-names>P.E.</given-names>
            </name>
          </person-group>
          <article-title>Protein structure alignment by incremental combinatorial extension (CE) of the optimal path</article-title>
          <source>Protein Eng.</source>
          <volume>11</volume>
          <year>1998</year>
          <fpage>739</fpage>
          <lpage>747</lpage>
          <pub-id pub-id-type="pmid">9796821</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0405">
        <label>81</label>
        <element-citation publication-type="journal" id="rf0405">
          <person-group person-group-type="author">
            <name>
              <surname>Petoukhov</surname>
              <given-names>M.V.</given-names>
            </name>
            <name>
              <surname>Franke</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Shkumatov</surname>
              <given-names>A.V.</given-names>
            </name>
            <name>
              <surname>Tria</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Kikhney</surname>
              <given-names>A.G.</given-names>
            </name>
            <name>
              <surname>Gajda</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>New developments in the ATSAS program package for small-angle scattering data analysis</article-title>
          <source>J. Appl. Crystallogr.</source>
          <volume>45</volume>
          <year>2012</year>
          <fpage>342</fpage>
          <lpage>350</lpage>
        </element-citation>
      </ref>
      <ref id="bb0410">
        <label>82</label>
        <element-citation publication-type="journal" id="rf0410">
          <person-group person-group-type="author">
            <name>
              <surname>Konarev</surname>
              <given-names>P.V.</given-names>
            </name>
            <name>
              <surname>Volkov</surname>
              <given-names>V.V.</given-names>
            </name>
            <name>
              <surname>Sokolova</surname>
              <given-names>A.V.</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>M.H.J.</given-names>
            </name>
            <name>
              <surname>Svergun</surname>
              <given-names>D.I.</given-names>
            </name>
          </person-group>
          <article-title>PRIMUS: a Windows PC-based system for small-angle scattering data analysis</article-title>
          <source>J. Appl. Crystallogr.</source>
          <volume>36</volume>
          <year>2003</year>
          <fpage>1277</fpage>
          <lpage>1282</lpage>
        </element-citation>
      </ref>
      <ref id="bb0415">
        <label>83</label>
        <element-citation publication-type="journal" id="rf0415">
          <person-group person-group-type="author">
            <name>
              <surname>Guinier</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>La diffraction des rayons X aux tres petits angles: application a l'etude de phenomenes ultramicroscopiques</article-title>
          <source>Ann. Phys. (Paris)</source>
          <volume>12</volume>
          <year>1939</year>
          <fpage>161</fpage>
          <lpage>237</lpage>
        </element-citation>
      </ref>
      <ref id="bb0420">
        <label>84</label>
        <element-citation publication-type="journal" id="rf0420">
          <person-group person-group-type="author">
            <name>
              <surname>Svergun</surname>
              <given-names>D.I.</given-names>
            </name>
          </person-group>
          <article-title>Determination of the regularization parameter in indirect-transform methods using perceptual criteria</article-title>
          <source>J. Appl. Crystallogr.</source>
          <volume>25</volume>
          <year>1992</year>
          <fpage>495</fpage>
          <lpage>503</lpage>
        </element-citation>
      </ref>
      <ref id="bb0425">
        <label>85</label>
        <element-citation publication-type="journal" id="rf0425">
          <person-group person-group-type="author">
            <name>
              <surname>Schwieters</surname>
              <given-names>C.D.</given-names>
            </name>
            <name>
              <surname>Clore</surname>
              <given-names>G.M.</given-names>
            </name>
          </person-group>
          <article-title>A physical picture of atomic motions within the Dickerson DNA dodecamer in solution derived from joint ensemble refinement against NMR and large-angle X-ray scattering data</article-title>
          <source>Biochemistry</source>
          <volume>46</volume>
          <year>2007</year>
          <fpage>1152</fpage>
          <lpage>1166</lpage>
          <pub-id pub-id-type="pmid">17260945</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0430">
        <label>86</label>
        <element-citation publication-type="journal" id="rf0430">
          <person-group person-group-type="author">
            <name>
              <surname>Volkov</surname>
              <given-names>V.V.</given-names>
            </name>
            <name>
              <surname>Svergun</surname>
              <given-names>D.I.</given-names>
            </name>
          </person-group>
          <article-title>Uniqueness of <italic>ab initio</italic> shape determination in small-angle scattering</article-title>
          <source>J. Appl. Crystallogr.</source>
          <volume>36</volume>
          <year>2003</year>
          <fpage>860</fpage>
          <lpage>864</lpage>
        </element-citation>
      </ref>
      <ref id="bb0435">
        <label>87</label>
        <element-citation publication-type="journal" id="rf0435">
          <person-group person-group-type="author">
            <name>
              <surname>Petoukhov</surname>
              <given-names>M.V.</given-names>
            </name>
            <name>
              <surname>Svergun</surname>
              <given-names>D.I.</given-names>
            </name>
          </person-group>
          <article-title>Global rigid body modeling of macromolecular complexes against small-angle scattering data</article-title>
          <source>Biophys. J.</source>
          <volume>89</volume>
          <year>2005</year>
          <fpage>1237</fpage>
          <lpage>1250</lpage>
          <pub-id pub-id-type="pmid">15923225</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0440">
        <label>88</label>
        <element-citation publication-type="journal" id="rf0440">
          <person-group person-group-type="author">
            <name>
              <surname>Eswar</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Eramian</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>M.Y.</given-names>
            </name>
            <name>
              <surname>Sali</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Protein structure modeling with MODELLER</article-title>
          <source>Methods Mol. Biol.</source>
          <volume>426</volume>
          <year>2008</year>
          <fpage>145</fpage>
          <lpage>159</lpage>
          <pub-id pub-id-type="pmid">18542861</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <glossary id="gl0005">
      <title>Glossary</title>
      <def-list>
        <def-item>
          <term>Complement</term>
          <def>
            <p>Approximately 30 proteins involved in multiple aspects of innate and acquired immunity.</p>
          </def>
        </def-item>
      </def-list>
      <def-list>
        <def-item>
          <term>Alternative pathway</term>
          <def>
            <p>Complement activation via spontaneous C3 hydrolysis; in contrast, antibodyâantigen complexes and polysaccharides are needed to activate the classical and lectin pathways, respectively.</p>
          </def>
        </def-item>
      </def-list>
      <def-list>
        <def-item>
          <term>C3</term>
          <def>
            <p>A complement protein that is cleaved by C3 convertase into C3a and C3b; cleavage activates a thioester group in C3b that is able to react with any nearby nucleophile.</p>
          </def>
        </def-item>
      </def-list>
      <def-list>
        <def-item>
          <term>C3(H<sub>2</sub>O)</term>
          <def>
            <p>A form of C3 in which the thioester has been spontaneously hydrolyzed; resembles C3b in domain arrangements and ability to form part of a C3 convertase complex.</p>
          </def>
        </def-item>
      </def-list>
      <def-list>
        <def-item>
          <term>C3 convertase</term>
          <def>
            <p>Binary complexâC3(H<sub>2</sub>O).Bb or C3b.Bbâthat cleaves C3 to C3a and C3b; formation involves C3b or C3(H<sub>2</sub>O) binding proenzyme factor B that subsequently gets cleaved (and activated) by factor D to Bb.</p>
          </def>
        </def-item>
      </def-list>
      <def-list>
        <def-item>
          <term>CCP modules</term>
          <def>
            <p>Domains, which predominate among regulators of complement activation, containing ~Â 60 amino acid residues and two disulfides.</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <sec id="s0120" sec-type="supplementary-material">
      <label>Appendix A</label>
      <title>Supplementary Data</title>
      <p>
        <supplementary-material content-type="local-data" id="ec0005">
          <caption>
            <p>Supplementary materials</p>
          </caption>
          <media xlink:href="mmc1.pdf"/>
        </supplementary-material>
      </p>
    </sec>
    <ack>
      <title>Acknowledgements</title>
      <p>This work was funded by the <funding-source id="gts0005">Wellcome Trust</funding-source> grants 073131 and 085025. H.D.T.M. was supported by a fellowship from the European Molecular Biology Laboratory Interdisciplinary Postdoctoral Programme. Use of the Edinburgh Protein Production Facility was supported by The Wellcome Trust, the Scottish University Life Sciences Alliance and the Biotechnology and Biological Sciences Research Council.</p>
    </ack>
    <fn-group>
      <fn id="fn0015">
        <label>â </label>
        <p>Available from <ext-link ext-link-type="uri" xlink:href="http://www.bionmr.chem.ed.ac.uk/bionmr/public_html/ccp-db.html">www.bionmr.chem.ed.ac.uk/bionmr/public_html/ccp-db.html</ext-link></p>
      </fn>
    </fn-group>
  </back>
  <floats-group>
    <fig id="f0010">
      <label>Fig.Â 1</label>
      <caption>
        <p>Gaps in structural knowledge of human complement FH. Drawn as ovals, CCPs are shaded to indicate C3b-binding regions or emboldened to signify GAG/sialic acid-recognition sites (CCPs 7 and 20 being the most strongly implicated). The number of residues in each inter-modular linker is written beneath; above is a schematic representation of the tilt angle (away from linearity) of a CCP's long axis with respect to the long axis of the preceding CCP [including (bold) FH 10â11 and FH 11â12 tilts measured herein]. The tilt between CCPs 18 and 19 was 122Â° in the FH 18â20 crystal structure,<xref rid="bb0180" ref-type="bibr"><sup>36</sup></xref> but SAXS suggested a more extended arrangement in solution. Structures solved by NMR or X-ray crystallography of recombinant segments of FH are summarized in the central portion of the figure. âCurrent workâ summarizes the recombinant constructs investigated and methods used for analysis.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="f0015">
      <label>Fig.Â 2</label>
      <caption>
        <p>NMR data ([<sup>1</sup>H,<sup>15</sup>N]HSQC spectra) for FH 10â11 and FH 11â12. Spectra [(a) FH 10â11; (b) FH 11â12] were collected in 30Â min on double-labeled samples (0.45Â mM and 0.65Â mM FH 10â11 and FH 11â12, respectively) at 25Â Â°C in 20Â mM potassium phosphate buffer (at pHÂ 6.7 and 6.3 for FH 10â11 and FH 11â12, respectively).</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="f0020">
      <label>Fig.Â 3</label>
      <caption>
        <p>SAXS data for FH constructs: pairwise interatomic distance distributions, <italic>p</italic>(<italic>r</italic>), for the following constructs derived from FH, FH 8â9, FH 10â11, FH 11â12, FH 10â12 and FH 8â15.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="f0025">
      <label>Fig.Â 4</label>
      <caption>
        <p>Solution (NOE-derived) structures of FH 10â11 and FH 11â12. (a) The 20 lowest-energy, water-minimized FH 10â11 structures, overlaid on backbone atoms of CCP 10 (blue), CCP 11 (magenta) or both modules CCP 10 and 11 (and linker; wheat ) (relevant rmsd values are shown). (b) As (a) except that NOE-derived structures of FH 11â12 (CCP 12 in gray) are overlaid. In the cartoon representations of (c) FH 10â11 and (d) FH 11â12, Î²âstrands identified by STRIDE were labeled AâH according to a convention whereby CCP modules have a maximum of eight Î²âstrands. Spheres represent cysteine side chains (sulfurs are colored yellow).</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <fig id="f0030">
      <label>Fig.Â 5</label>
      <caption>
        <p>Interâmodular interfaces in FH 10â11 and FH 11â12. (a) Side chains of residues involved in the interfaces drawn as color-coded labeled spheres: blue for CCP 10, magenta for CCP 11 and gray for CCP 12; wheat for the CCP 10â11 or the CCP 11â12 linker. (b) With the use of identical color coding, solvent-accessible surfaces are drawn, illustrating more extensive contacts between CCPs 11 and 12 despite larger tilt angle between CCPs 10 and 11.</p>
      </caption>
      <graphic xlink:href="gr5"/>
    </fig>
    <fig id="f0035">
      <label>Fig.Â 6</label>
      <caption>
        <p>Structure of FH 10â12. (a) Overview of construction of the FH 10â12 model from concatenation of the FH 10â11 and FH 11â12 NMR structures. (b) Cartoon representation of a model of FH 10â12 built by concatenating structures of FH 10â11 and FH 11â12. Models are rotated about the horizontal axis by 90Â° and 180Â° relative to the topmost representation, respectively (for color coding, see <xref rid="f0025" ref-type="fig">Fig.Â 4</xref>). (c) Scattering curve of FH 10â12 fitted to the concatenated structure allows validation of the model.</p>
      </caption>
      <graphic xlink:href="gr6"/>
    </fig>
    <fig id="f0040">
      <label>Fig.Â 7</label>
      <caption>
        <p>Applications of the ensemble optimization method. (a) In FH 10â12, individual CCPs were defined as rigid bodies but linkers were allowed to be flexible. Comparison of size distributions shows that an ensemble of structures selected from the pool (continuous line) that fit optimally to the SAXS data for FH 10â12 is more compact than the pool of random structures (broken line). (b) As in (a) except that, in this case, only the CCP 10â11 linker was permitted flexibility. Size distributions are consistent with a rigid arrangement of CCPs 10 and 11 despite limited contacts between modules. (c) An application of EOM to FH 8â15; all individual CCPs along with CCP pairs 10â11, 11â12 and 12â13 were defined as rigid bodies while other linkers were treated as flexible. The selected ensemble indicates a mixture of compact and extended conformers consistent with flexible attachment of CCPs 8 and 9 to a compact, relatively rigid core of CCPs 10â15.</p>
      </caption>
      <graphic xlink:href="gr7"/>
    </fig>
    <fig id="f0045">
      <label>Fig.Â 8</label>
      <caption>
        <p>A model of FH 10â13 helps interpret SAXS data for FH 10â15. (a) Cartoon representation of a concatenated model of FH 10â13. (b) Two typical members of a convergent set of molecular structures that fit well to SAXS data for FH 10â15 interpreted on the assumption that CCPs 10â13 retain the spatial arrangement shown in (a), shown overlaid with the reconstructed SAXS envelope from DAMMIF. (c) A cartoon representation of CCPs 10â15 derived from SAXS data. (d) Zoom-in on CCPs 13â15 of SAXS-derived model; CCPs 14 and 15 bend over the CCP 12â13 linker in this model. Asterisks indicate 13â14 and 14â15 linkers that were built into the fitted structure manually (using MODELLER) since they were treated as dummy atoms during the fitting procedure.</p>
      </caption>
      <graphic xlink:href="gr8"/>
    </fig>
    <table-wrap id="t0005" position="float">
      <label>TableÂ 1</label>
      <caption>
        <p>SAXS parameters for FH fragments</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left">Construct</th>
            <th align="center"><italic>R</italic><sub>g</sub><sup>autoRg</sup> (nm)</th>
            <th align="center"><italic>R</italic><sub>g</sub><sup>GNOM</sup> (nm)</th>
            <th align="center"><italic>D</italic><sub>max</sub> (nm)</th>
            <th align="center"><italic>V</italic><sub>p</sub> (nm<sup>3</sup>)</th>
            <th align="center">MM<sub>SAXS</sub> (kDa)</th>
            <th align="center"><italic>V</italic><sub>DAM</sub> (nm<sup>3</sup>)</th>
            <th align="center">MM<sub>DAM</sub> (kDa)</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">FH 8â9 (13.7Â kDa)</td>
            <td align="char">2.1Â Â±Â 0.1</td>
            <td align="char">2.2Â Â±Â 0.1</td>
            <td align="char">7.5Â Â±Â 0.5</td>
            <td align="char">21Â Â±Â 5</td>
            <td align="char">15Â Â±Â 5</td>
            <td align="char">23Â Â±Â 5</td>
            <td align="char">11Â Â±Â 5</td>
          </tr>
          <tr>
            <td align="left">FH 10â11 (13.9Â kDa)</td>
            <td align="char">2.2Â Â±Â 0.1</td>
            <td align="char">2.2Â Â±Â 0.1</td>
            <td align="char">7.5Â Â±Â 0.5</td>
            <td align="char">22Â Â±Â 5</td>
            <td align="char">16Â Â±Â 5</td>
            <td align="char">21Â Â±Â 5</td>
            <td align="char">10Â Â±Â 5</td>
          </tr>
          <tr>
            <td align="left">FH 11â12 (14.1Â kDa)</td>
            <td align="char">2.4Â Â±Â 0.1</td>
            <td align="char">2.3Â Â±Â 0.1</td>
            <td align="char">8.3Â Â±Â 0.5</td>
            <td align="char">25Â Â±Â 5</td>
            <td align="char">19Â Â±Â 5</td>
            <td align="char">25Â Â±Â 5</td>
            <td align="char">12Â Â±Â 5</td>
          </tr>
          <tr>
            <td align="left">FH 10â12 (20.6Â kDa)</td>
            <td align="char">2.7Â Â±Â 0.1</td>
            <td align="char">2.7Â Â±Â 0.1</td>
            <td align="char">9.5Â Â±Â 0.5</td>
            <td align="char">33Â Â±Â 5</td>
            <td align="char">20Â Â±Â 5</td>
            <td align="char">47Â Â±Â 5</td>
            <td align="char">24Â Â±Â 5</td>
          </tr>
          <tr>
            <td align="left">FH 8â15 (54.7Â kDa)</td>
            <td align="char">3.5Â Â±Â 0.1</td>
            <td align="char">3.7Â Â±Â 0.1</td>
            <td align="char">12.5Â Â±Â 0.5</td>
            <td align="char">92Â Â±Â 10</td>
            <td align="char">62Â Â±Â 5</td>
            <td align="char">93Â Â±Â 10</td>
            <td align="char">47Â Â±Â 5</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p><italic>R</italic><sub>g</sub><sup>autoRg</sup> and <italic>R</italic><sub>g</sub><sup>GNOM</sup> are the radii of gyration estimated from the SAXS data using the automated Guinier analysis routine and GNOM, respectively. <italic>D</italic><sub>max</sub>, <italic>V</italic><sub>p</sub>, <italic>V</italic><sub>DAM</sub>, MM<sub>SAXS</sub> and MM<sub>DAM</sub> are the maximum particle dimension, hydrated particle volume, dummy-atom model total excluded volume, molecular mass estimated from <italic>I</italic>(0) and molecular mass estimated from the dummy-atom model volume, respectively. The data shown are averaged or merged and extrapolated to infinite dilution, using the SAXS profiles recorded at several concentrations. The molecular mass calculated from the sequence is shown in parentheses.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="t0010" position="float">
      <label>TableÂ 2</label>
      <caption>
        <p>Statistics for solution structures of FH 10â11 and FH 11â12</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left">Segment</th>
            <th align="center">FH 10â11</th>
            <th align="center">FH 11â12</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td colspan="3" align="left">Numbers of NOE-derived distance restraints</td>
          </tr>
          <tr>
            <td align="left">Â Intraresidue, |<italic>i</italic>Â âÂ <italic>j</italic>|Â â¤Â 1</td>
            <td align="center">1405</td>
            <td align="center">1482</td>
          </tr>
          <tr>
            <td align="left">Â Medium range, 1Â &lt;Â |<italic>i</italic>Â âÂ <italic>j</italic>|Â &lt;Â 5</td>
            <td align="center">411</td>
            <td align="center">301</td>
          </tr>
          <tr>
            <td align="left">Â Long range, |<italic>i</italic>Â âÂ <italic>j</italic>|Â â¥Â 5</td>
            <td align="center">1391</td>
            <td align="center">1322</td>
          </tr>
          <tr>
            <td align="left">Â Total</td>
            <td align="center">3207</td>
            <td align="center">3105</td>
          </tr>
          <tr>
            <td align="left">Interâmodular<xref rid="tf0005" ref-type="table-fn">a</xref></td>
            <td align="center">8</td>
            <td align="center">38</td>
          </tr>
          <tr>
            <td align="left">N-module to linker</td>
            <td align="center">62</td>
            <td align="center">89</td>
          </tr>
          <tr>
            <td align="left">C-module to linker</td>
            <td align="center">65</td>
            <td align="center">39</td>
          </tr>
          <tr>
            <td colspan="3" align="left">rmsd values (Ã) (superimposition of ensemble over entire sequence)</td>
          </tr>
          <tr>
            <td align="left">Â All atoms</td>
            <td align="center">1.17</td>
            <td align="center">1.05</td>
          </tr>
          <tr>
            <td align="left">Â Backbone atoms</td>
            <td align="center">0.91</td>
            <td align="center">0.84</td>
          </tr>
          <tr>
            <td colspan="3" align="left">rmsd values (Ã) (superimposition of ensemble over N-terminal CCP)</td>
          </tr>
          <tr>
            <td align="left">Â All atoms</td>
            <td align="center">0.79</td>
            <td align="center">0.73</td>
          </tr>
          <tr>
            <td align="left">Â Backbone atoms</td>
            <td align="center">0.50</td>
            <td align="center">0.33</td>
          </tr>
          <tr>
            <td colspan="3" align="left">rmsd values (Ã) (superimposition of ensemble over C-terminal CCP)</td>
          </tr>
          <tr>
            <td align="left">Â All atoms</td>
            <td align="center">0.74</td>
            <td align="center">0.72</td>
          </tr>
          <tr>
            <td align="left">Â Backbone atoms</td>
            <td align="center">0.33</td>
            <td align="center">0.43</td>
          </tr>
          <tr>
            <td colspan="3" align="left">Interâmodular angles (Â°) [minimumâmaximum (meanÂ Â±Â SD)]</td>
          </tr>
          <tr>
            <td align="left">Â Skew</td>
            <td align="center">75â107 (89Â Â±Â 8)</td>
            <td align="center">149â170 (158Â Â±Â 4)</td>
          </tr>
          <tr>
            <td align="left">Â Twist</td>
            <td align="center">40â78 (57Â Â±Â 10)</td>
            <td align="center">59â87 (72Â Â±Â 7)</td>
          </tr>
          <tr>
            <td align="left">Â Tilt</td>
            <td align="center">111â128 (118Â Â±Â 5)</td>
            <td align="center">76â99 (88Â Â±Â 6)</td>
          </tr>
          <tr>
            <td colspan="3" align="left">Ramachandran assessment (%)</td>
          </tr>
          <tr>
            <td align="left">Â Most favored</td>
            <td align="center">80.5</td>
            <td align="center">74.6</td>
          </tr>
          <tr>
            <td align="left">Â Additionally allowed</td>
            <td align="center">16.4</td>
            <td align="center">22.4</td>
          </tr>
          <tr>
            <td align="left">Â Generously allowed</td>
            <td align="center">1.3</td>
            <td align="center">1.7</td>
          </tr>
          <tr>
            <td align="left">Â Disallowed</td>
            <td align="center">1.8</td>
            <td align="center">1.3</td>
          </tr>
          <tr>
            <td align="left">Surface area buried between modules (Ã<sup>2</sup>)<xref rid="tf0010" ref-type="table-fn">b</xref></td>
            <td align="center">358</td>
            <td align="center">642</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tf0005">
          <label>a</label>
          <p>Module boundaries defined by the first and the last cysteine of each CCP module.</p>
        </fn>
      </table-wrap-foot>
      <table-wrap-foot>
        <fn id="tf0010">
          <label>b</label>
          <p>This value is for the closest-to-mean structures in each ensembles (see <xref rid="s0055" ref-type="sec">Materials and Methods</xref>).</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>